Viral meningitis: an overview
Open accessAbstract
Meningitis is a serious condition that affects the central nervous system. It is an inflammation of the meninges, which is the membrane that surrounds both the brain and the spinal cord. Meningitis can be caused by bacterial, viral, or fungal infections. Many viruses, such as enteroviruses, herpesviruses, and influenza viruses, can cause this neurological disorder. However, enteroviruses have been found to be the underlying cause of most viral meningitis cases worldwide. With few exceptions, the clinical manifestations and symptoms associated with viral meningitis are similar for the different causative agents, which makes it difficult to diagnose the disease at early stages. The pathogenesis of viral meningitis is not clearly defined, and more studies are needed to improve the health care of patients in terms of early diagnosis and management. This review article discusses the most common causative agents, epidemiology, clinical features, diagnosis, and pathogenesis of viral meningitis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
72 of 133 cited sources checked · 24 supported · 4 flagged · accuracy not yet measured
- Premisecitation
The diagnostic accuracy of Brudzinski's sign, Kernig's sign, and nuchal rigidity does not differ significantly between meningitis cases and normal cases.
“Although these signs are widely used, studies have shown that the diagnostic accuracy of these physical assessments are not significantly different between meningitis cases and normal cases [26].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [26] Mehndiratta M et al (2012) Appraisal of Kernig’s and Brudzinski’s sign in meningitis. Ann Indian Acad Neurol 15(4):287 source
The Historical origin and clinical aspects section (p. 2) says Kernig’s and Brudzinski’s signs have low sensitivity but high specificity: when present, they suggest a high likelihood of meningitis. It does not report a statistical comparison with normal cases, and its conclusion runs contrary to the claim that these signs have no meaningful diagnostic difference between cases and non-cases. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
In the United Kingdom, the incidence of viral meningitis caused by enterovirus and human parechovirus is twice that of bacterial meningitis.
“Another study in the United Kingdom (UK) showed that the incidence of viral meningitis caused by EV and human parechovirus (HPeV) is double that of bacterial meningitis [9].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [9] Kadambari S et al (2019) Enterovirus and parechovirus meningitis in infants younger than 90 days old in the UK and Republic of Ireland: a British Paediatric Surveillance Unit study. Arch Dis Child 104(6):552–557 source
The Discussion reports that laboratory-confirmed EV/HPeV meningitis occurred at more than twice the estimated incidence of bacterial meningitis. The comparison is specifically for infants younger than 90 days in the UK and Republic of Ireland; the citing sentence omits that age restriction and presents the finding as applying to the UK generally. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
A case report from Japan described a 24-year-old male with aseptic meningitis caused by SARS-CoV-2, confirmed by RT-PCR on a CSF sample.
“The most recently detected viral agent causing meningitis was reported in a case study of a 24-year-old male from Japan who had aseptic meningitis caused by SARS-CoV-2, which was demonstrated by performing an RT-PCR test on a CSF sample from the patient.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [14] Moriguchi T et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58 source
- Premisecitation
After entering the body, enteroviruses replicate mainly in epithelial cells of the nasopharynx and the oropharyngeal and intestinal mucosa.
“As the virus enters the body, it replicates mainly in the epithelium cells of the nasopharynx and the oropharyngeal and intestinal mucosa [56].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] Majer A, McGreevy A, Booth TF (2020) Molecular pathogenicity of enteroviruses causing neurological disease. Front Microbiol 11:540 source
The Routes of Enterovirus Neuroinvasion section (page unavailable) says that enteroviruses replicate in the gastrointestinal tract or, for EV-D68, the lungs during early disease, and that poliovirus primarily infects gastrointestinal epithelia. It does not identify the nasopharynx or oropharyngeal mucosa as main replication sites, so the cited paper supports only part of the claimed tissue distribution. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
A proposed route of coxsackievirus entry to the central nervous system is through infected mononuclear cells (Mac-3) that penetrate the blood-brain barrier and invade the choroid plexus epithelium, allowing spread of the virus into the central nervous system.
“A proposed route of coxsackievirus entry to the CNS is through infected mononuclear cells (Mac-3) that can penetrate the BBB and invade the choroid plexus epithelium, allowing the spread of the virus into the CNS [64, 65].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [64] Tabor-Godwin JM et al (2010) A novel population of myeloid cells responding to coxsackievirus infection assists in the dissemination of virus within the neonatal CNS. J Neurosci 30(25):8676–8691 source
The Results section (‘Infected myeloid cells extravasate through the choroid plexus and into the ependymal cell layer’; page not provided) proposes that infected myeloid cells carry CVB3 through the choroid plexus into the neonatal CNS. It identifies this route as crossing the blood-CSF barrier, not the blood-brain barrier (BBB) named in the claim. The Discussion (page not provided) identifies the recruited cells as Mac3+ upon entry. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [65] Huang H-I, Shih S-R (2015) Neurotropic enterovirus infections in the central nervous system. Viruses 7(11):6051–6066 source
Section 3 (page unavailable) says coxsackievirus infects Mac-3+ mononuclear cells that migrate toward the CNS and enter the brain through the choroid plexus epithelium. Section 7 (page unavailable) discusses nestin-positive myeloid cells crossing the blood-brain barrier, but does not identify them as the infected Mac-3+ cells. The specific claim that those cells penetrate the barrier is therefore not established by this copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
EV-71 and coxsackievirus B have been detected in undifferentiated neural progenitor cells in mice after infection.
“For example, EV-71 and coxsackievirus B have been detected in undifferentiated neural progenitor cells in mice after infection [58, 59].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [58] Huang H-I et al (2014) Enterovirus 71 infects brain-derived neural progenitor cells. Virology 468–470:592–600 source
- cites [59] Puccini JM et al (2014) Distinct neural stem cell tropism, early immune activation, and choroid plexus pathology following coxsackievirus infection in the neonatal central nervous system. Lab Invest 94(2):161–181 source
- Premisecitation
In a murine viral meningitis model infected with lymphocytic choriomeningitis virus, levels of both IL-6 and INF-γ were elevated in CSF.
“One study using a murine viral meningitis model in which mice were infected with lymphocytic choriomeningitis virus (LCMV) showed elevated levels of both IL-6 and INF-γ in CSF [50].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [50] Frei K et al (1988) Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med 168(1):449–453 source
- Premisecitation
Dissemination of the virus leads to different complications, such as meningitis and encephalitis.
“This dissemination of the virus leads to different complications, such as meningitis and encephalitis [62].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [62] de Crom SCM et al (2016) Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr 175(8):1023–1029 source
- Premisecitation
Once the viral agent enters the central nervous system, increased levels of chemoattractants, neutrophils, CD8 T cells, and monocytes are detected, indicating induction of an immune response.
“Once the viral agent enters the CNS, increased levels of chemoattractants, neutrophils, CD8 T cells, and monocytes are detected, indicating the induction of an immune response [46].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [46] Kim JV et al (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457(7226):191–195 source
- Premisecitation
Enteroviruses infect different neural cells, such as glia cells and astrocytes.
“Various studies have shown that EVs infect different neural cells, such as glia cells and astrocytes [56].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] Majer A, McGreevy A, Booth TF (2020) Molecular pathogenicity of enteroviruses causing neurological disease. Front Microbiol 11:540 source
- Premisecitation
There is a lack of evidence for the efficacy of corticosteroids against viral meningitis.
“Although corticosteroids are commonly given in cases of suspected bacterial meningitis to reduce the inflammatory effect that accompanies the disease, there is a lack of evidence of their efficacy against viral meningitis, and more studies are still needed [97].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [97] Bookstaver PB et al (2017) Management of viral central nervous system infections: a primer for clinicians. J Cent Nerv Syst Dis 9:1179573517703342–1179573517703342 source
The Herpes viruses section (page not provided) says corticosteroids are not routinely recommended for herpes simplex encephalitis and that randomized studies are needed to confirm benefit. It also says clinical outcome data for corticosteroids in acute Epstein–Barr virus infections are lacking. These findings support the concern about insufficient evidence, but the paper does not establish it specifically for viral meningitis as a whole. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
Major members of the family Herpesviridae that can cause meningitis include human herpesvirus 1 and 2, varicella-zoster virus, and Epstein-Barr virus.
“Major members of the family Herpesviridae that can cause meningitis include human herpesvirus 1 and 2 (HSV-1 and HSV-2), varicella-zoster virus (VZV), and Epstein-Barr virus (EBV) [82].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Spear PG, Longnecker R (2003) Herpesvirus entry: an update. J Virol 77(19):10179–10185 source
The opening overview (page not specified in our copy) says HSV-1 and HSV-2 can cause meningitis. It identifies VZV and EBV as human herpesviruses but does not say that either can cause meningitis, so the claim is supported only for HSV-1 and HSV-2. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
In a study by Lee et al. on aseptic meningitis, E-30 was found to affect the triple functional domain protein, leading to neural damage.
“In a study by Lee et al. on aseptic meningitis, it was found that E-30 affects the triple functional domain (TRIO) protein, leading to neural damage (Fig. 2) [71].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [71] Lee J-W et al (2012) Echovirus 30 induced neuronal cell death through TRIO-RhoA signaling activation. PLoS ONE 7(5):e36656–e36656 source
- Premisecitation
To date, no receptor has been identified for HPeV-3.
“To date, no receptor has been identified for HPeV-3 [81] that would explain its different tropism.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [81] Karelehto E et al (2018) Polarized entry of human parechoviruses in the airway epithelium. Front Cell Infect Microbiol 8:294–294. https://doi.org/10.3389/fcimb.2018.00294 source
- Premisecitation
Pleconaril is an antiviral drug that inhibits enterovirus replication by targeting the viral capsid structure.
“Pleconaril is an antiviral drug that acts as an inhibitor of enterovirus replication by targeting the viral capsid structure [98].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [98] Pevear DC et al (1999) Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother 43(9):2109 source
- Premisecitation
EV-D68 can reach the central nervous system through binding to functional receptors of the olfactory nerve in the nasal cavity.
“In addition, EV-D68 can reach the CNS through binding to the functional receptors of the olfactory nerve in the nasal cavity [76].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [76] Messacar K et al (2018) Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Lancet Infect Dis 18(8):e239–e247 source
The Introduction’s “Coherence” section proposes a functional EV-D68 receptor on olfactory nerve endings in the upper nasal cavity as a potential route into the CNS. It describes that route as a possibility, not an established way that EV-D68 reaches the CNS, so the citing sentence overstates the evidence. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
The FDA did not approve the oral usage of pleconaril because it induces CYP3A enzyme activity, resulting in drug interactions, especially with oral contraceptives.
“The FDA did not approve the oral usage of the drug because it induces CYP3A enzyme activity, resulting in a drug interaction, especially with oral contraceptives [101].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [101] Paintsil E, Cheng Y-C (2009) Antiviral agents. In: Schaechter M (ed) Encyclopedia of microbiology (Third Edition). Academic Press, Oxford, pp 223–257 source
The Future Prospects section says pleconaril had not been licensed for treatment of enteroviral infections. It does not identify an FDA decision about oral use or attribute nonapproval to CYP3A induction and interactions with oral contraceptives; the Pleconaril section discusses oral dosing and adverse effects without making those connections. Page numbers were not provided in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
EV-D68 binds to the cellular receptor ICAM-5/telencephalin, which is expressed in dendrites and some neurons, to enter the cell.
“It has also been found that the virus binds to the cellular receptor ICAM-5/telencephalin, which is expressed in dendrites and some neurons, to enter the cell [74, 75].”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
Studies have shown that the influenza virus enters the central nervous system by the olfactory route and other cranial nerves.
“Studies have shown that the influenza virus enters the CNS by the olfactory route [90] and other cranial nerves [91].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [90] Yamada M et al (2012) Multiple routes of invasion of wild-type Clade 1 highly pathogenic avian influenza H5N1 virus into the central nervous system (CNS) after intranasal exposure in ferrets. Acta Neuropathol 124(4):505–516 source
- cites [91] Siegers JY et al (2019) Viral factors important for efficient replication of influenza A viruses in cells of the central nervous system. J Virol 93(11):e02273-e2318 source
- Premisecitation
Typically, the influenza virus binds to α2,6-linked sialic acid and α2,3-linked sialic acid found on epithelial cells of the upper and lower respiratory tract.
“Typically, the virus binds to α2,6-linked sialic acid and α2,3-linked sialic acid found on epithelial cells of the upper and lower respiratory tract [92].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [92] Imai M, Kawaoka Y (2012) The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol 2(2):160–167 source
The receptor-binding specificity section says influenza HA binds sialic-acid-containing glycans on epithelial cells, but distinguishes human strains, which preferentially bind α2,6-linked receptors, from avian strains, which prefer α2,3-linked receptors. It reports predominantly α2,6-linked receptors in the human upper respiratory tract; it does not establish the claimed receptor distribution in the lower respiratory tract. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
HPeV-3 utilizes an RBS-receptor binding site other than the arginine-glycine-glutamic acid sequence motif at the carboxyl terminus of VP that is utilized by other HPeV serotypes.
“Moreover, it has been found that HPeV-3 utilizes an RBS-receptor binding site other than the arginine-glycine-glutamic acid sequence motif at the carboxyl terminus of VP (capsid protein) that is utilized by the other serotypes of HPeV [80].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [80] Westerhuis B (2014) The 3-dimensional play of human parechovirus infection; cell, virus and antibody
In “The role of the RGD motif in infection” (page unavailable), the paper says HPeV3 lacks the VP1 C-terminal RGD motif found in HPeV1, 2, 4, 5 and 6. It says different receptor usage is implied but has not been determined, so the claim overstates this as an established alternative binding site. The motif is arginine-glycine-aspartic acid, not arginine-glycine-glutamic acid; the paper also notes that some other HPeV types lack it. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
For arboviruses, viral entry can occur through skin bites from infected arthropods, resulting in regional lymph node infection, viremia, and spread to the central nervous system, leading to meningitis.
“In the case of the arboviruses, viral entry can occur through skin bites from infected arthropods, which results in regional lymph node infection, viremia, and spread to the CNS, leading to meningitis [29].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Irani DN (2008) Aseptic meningitis and viral myelitis. Neurol Clin 26(3):635 source
- Premisecitation
α2,6-linked sialic acid and α2,3-linked sialic acid receptors are also found in neurons of the cerebral cortex and brainstem.
“However, a study showed that α2,6-linked sialic acid and α2,3-linked sialic acid receptors are also found in neurons of the cerebral cortex and brainstem [91, 93].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [91] Siegers JY et al (2019) Viral factors important for efficient replication of influenza A viruses in cells of the central nervous system. J Virol 93(11):e02273-e2318 source
- cites [93] Kim M et al (2013) Comparative analyses of influenza virus receptor distribution in the human and mouse brains. J Chem Neuroanat 52:49–57 source
- Premisecitation
Enteroviruses are the most frequent cause of viral meningitis globally.
“However, enteroviruses have been found to be the underlying cause of most viral meningitis cases worldwide.”
- Also stated in: § Introduction · plain
“Enteroviruses (EVs) are the most common causative agents of viral meningitis, with an estimated 75,000 new cases annually in the United States [6].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] Desmond R et al (2006) Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 50(7):2409–2414 source
- Also stated in: § Introduction · plain
- Premisecitation
A study found that 47% of subjects with enteroviral meningitis had neutrophilic pleocytosis.
“Moreover, a study showed that 47% of study subjects with enteroviral meningitis had neutrophilic pleocytosis [40].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Méchaï F et al (2010) Caractéristiques clinicobiologiques des méningites à Enterovirus de l’adulte : étude de 59 cas. La Revue de Médecine Interne 31(9):596–599 source
- Premisecitation
A lactic acid concentration of at least 4.2 mmol/l can differentiate viral from bacterial meningitis with 100% specificity.
“In addition, the concentration of lactic acid (≥ 4.2 mmol/l) can be used to differentiate between viral and bacterial meningitis with 100% specificity [34].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Buch K et al (2018) Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis/encephalitis in adults: a Danish prospective observational cohort study. Infect Dis (Lond) 50(7):514–521 source
- Premisecitation
Increased levels of IL-1β, a pro-inflammatory cytokine, were found in patients with aseptic meningitis.
“Another study showed an increased level of IL-1β (a pro-inflammatory cytokine) in patients with aseptic meningitis [51].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [51] Ramilo O et al (1990) Detection of interleukin 1β but not tumor necrosis factor—α in cerebrospinal fluid of children with aseptic meningitis. Am J Dis Child 144(3):349–352 source
- Premisecitation
This entry leads to activation of extracellular signal-regulated kinases 1 and 2, subsequently promoting viral replication inside leukocytes, mainly T cells.
“This leads to the activation of extracellular signal-regulated kinases 1 and 2 (ERK-1/2), subsequently promoting viral replication inside leukocytes, mainly T cells [66].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [66] Opavsky MA et al (2002) Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Investig 109(12):1561–1569 source
- Premisecitation
Coxsackievirus B, a member of the species Enterovirus B, is known to cause meningitis and other neurological disorders.
“Coxsackievirus B, a member of the species Enterovirus B, is known to cause meningitis and other neurological disorders [63].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [63] Berger JR et al (2006) Persistent coxsackie B encephalitis: report of a case and review of the literature. J NeuroVirol 12(6):511–516 source
- Premisecitation
In pediatric EV-positive meningitis cases, RT-PCR of CSF samples had 100% sensitivity, compared with 38% sensitivity for viral culture.
“A study of EV-positive meningitis cases in pediatric patients showed that testing of CSF samples by real-time PCR (RT-PCR) resulted in 100% sensitivity, compared to only 38% sensitivity when using viral culture.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] De Crom S et al (2013) Prospective comparison of the detection rates of human enterovirus and parechovirus RT-qPCR and viral culture in different pediatric specimens. J Clin Virol 58(2):449–454 source
- Premisecitation
Echoviruses use a specific integrin (α2 β1, very late antigen 2) and decay-accelerating factor as receptors to infect host cells, causing meningitis and febrile illness.
“Different studies have shown that echoviruses use a special type of integrin (α2 β1, very late antigen 2 [VLA-2]) and decay-accelerating factor as receptors to infect host cells to cause meningitis and febrile illness [70].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [70] Stewart PL, Dermody TS, Nemerow GR (2003) Structural basis of nonenveloped virus cell entry. Adv Protein Chem 64:455–491 source
- Premisecitation
The major neurological consequences of HSV are encephalitis and meningitis.
“The major neurological consequences of HSV are encephalitis and meningitis [83, 84].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [83] Bergström T et al (1990) Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis 162(2):322–330 source
- cites [84] Whitley RJ, Lakeman F (1995) Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis 20(2):414–420 source
- Premisecitation
HPeV-3 is the HPeV type most commonly associated with viral meningitis.
“HPeV-3 is the HPeV type that is most commonly associated with viral meningitis [79].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Wolthers KC et al (2008) Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Clin Infect Dis 47(3):358–363 source
- Interpretationreasoning
West Nile virus infection can trigger the development of various neurological complications, including meningitis.
“Therefore, WNV infection can trigger the development of various neurologica1 complications, including meningitis.”
Quote in the paperNot a substantial claim - Premisecitation
West Nile virus commonly causes West Nile neuroinvasive disorders, such as aseptic meningitis, paralysis, and encephalitis.
“West Nile virus commonly causes West Nile neuroinvasive disorders (WNNDs), such as aseptic meningitis, paralysis, and encephalitis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Lim P-Y et al (2011a) Keratinocytes are cell targets of West Nile virus in vivo. J Virol 85(10):5197–5201 source
- Premisecitation
HPeV can also cause neurological diseases such as meningitis and encephalitis, particularly in children.
“However, it can also cause neurological diseases, such as meningitis and encephalitis, particularly in children [78].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [78] Johannessen I, Burns SM (2012) 48—picornaviruses: meningitis; paralysis; rashes; intercostal myositis; myocarditis; infectious hepatitis; common cold. In: Greenwood D et al (eds) Medical microbiology (Eighteenth Edition). Churchill Livingstone, Edinburgh, pp 483–496 source
- Interpretationreasoning
The neuropathogenesis of EV-D68 and its ability to infect neuron cells may highlight a potential link between EV-D68 infection and aseptic meningitis.
“The neuropathogenesis of EV-D68 and its ability to infect neuron cells may highlight the potential link between EV-D68 infection and aseptic meningitis.”
Quote in the paperNot a substantial claim - Premisecitation
The most important arbovirus associated with central nervous system complications is West Nile virus.
“The most important arbovirus associated with CNS complications is WNV [94].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] Miller BR (2008) Arboviruses. In: Mahy BWJ, Van Regenmortel MHV (eds) Encyclopedia of virology (Third Edition). Academic Press, Oxford, pp 170–176 source
- May combine two claims. 69
- Classified as probably not a substantial claim. 32
May combine two claims.
PremisecitationPCR is the gold standard for diagnosing viral meningitis, detecting and quantifying viral DNA or RNA in the patient's CSF.
“The gold standard tool for diagnosis of viral meningitis is the polymerase chain reaction (PCR), which detects and quantifies viral DNA or RNA in the patient’s CSF [41].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [41] Verstrepen WA et al (2001) Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay. J Clin Microbiol 39(11):4093–4096 source
The paper’s introductory passage explicitly calls viral culture the “gold standard” for diagnosing enteroviral infections in CSF and describes RT-PCR as an alternative. Its assay detects and quantifies enterovirus RNA, but it does not establish PCR as the gold standard for viral meningitis generally. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn bacterial meningitis, CSF typically shows a WBC count of at least 500 cells/μl with more than 80% neutrophils, glucose not exceeding 300 mg/dL, a decreased CSF/blood glucose ratio below 0.4, and an elevated protein level of 1 g/l.
“For instance, a high WBC count (≥ 500 cells/μl) with a large proportion of neutrophils (>80%) is usually observed in bacterial meningitis. Furthermore, in bacterial meningitis, the CSF glucose level typically does not exceed (300 mg/dL), but a decreased glucose CSF/blood ratio (< 0.4), and an elevated protein level (1 g/l) are indications of bacterial meningitis [2].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [2] Hoffman O, Weber JR (2009) Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord 2(6):401–412 source
The Laboratory tests passage (Introduction; page not available) gives the opposite inequalities for three cited thresholds: WBC <500 cells/μl, protein <1 g/l, and CSF/blood glucose ratio >0.4. It supports predominant neutrophils but gives no >80% threshold or CSF glucose limit of 300 mg/dL. The verdict follows the inequalities as printed in our copy. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationEV-D68 binds to the N-acetylneuraminic acid α2,6-galactose receptor on epithelial cells, which is predominant in the upper respiratory tract, and this could explain the limited spread of the virus and its rare progression to neurological complications such as meningitis.
“As the virus enters the upper respiratory tract (URT), it binds to the N-acetylneuraminic acid α2,6-galactose receptor found on the surface of the epithelial cells. This receptor is predominant in the upper respiratory tract (URT) [73], which could explain the limited spread of the virus and its rare progression to neurological complications, such as meningitis.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [73] Esposito S et al (2015) Enterovirus D68 infection. Viruses 7(11):6043–6050 source
Split into 2 atoms — 1 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn Egypt, 573 of 1337 meningitis cases (42.86%) from 2013 to 2015 were due to viral infections.
“Additionally, a three-year study (2013-2015) in Egypt indicated that 573 out of 1337 meningitis cases (42.86%) were due to viral infections [18].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] Abdelkader MM et al (2017) Prevalence of MDR pathogens of bacterial meningitis in Egypt and new synergistic antibiotic combinations. PLoS ONE 12(2):e0171349–e0171349 source
The Results > Data analysis section reports 573 of 1,337 specimens (42.86%) as *possibly* viral meningitis. It describes a two-year study from September 2013 to September 2015, not a three-year study, and includes specimens classified as potentially misdiagnosed cases. The source therefore does not establish that 573 confirmed meningitis cases were due to viral infections. (LLM, conf=0.90)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn South Africa, children under 10 years of age made up 87.3% of those affected in an aseptic meningitis outbreak caused by coxsackievirus A9.
“In South Africa, children less than 10 years of age constituted 87.3% of those affected by an aseptic meningitis outbreak in which the responsible pathogen was coxsackievirus A9 [12].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [12] Smuts H et al (2018) Molecular characterization of an outbreak of enterovirus-associated meningitis in Mossel Bay, South Africa, December 2015-January 2016. BMC Infect Dis 18(1):709–709 source
The Abstract Results report that 55 of 63 patients (87.3%) were under 10, and the Conclusions identify coxsackievirus A9 as responsible for the South African outbreak. But the Results distinguish those 63 enterovirus-positive patients from the 43 cases classified as part of the outbreak. The paper does not establish that 87.3% of the outbreak cases were under 10. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationViral meningitis is the most frequent form of aseptic meningitis and usually affects young children.
“Viral meningitis is the most common type of aseptic meningitis and usually affects young children [1].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [1] Logan SA, MacMahon E (2008a) Viral meningitis. BMJ 336(7634):36–40 source
The ‘How common is viral meningitis?’ section says viral meningitis is most common in young children. The paper defines aseptic meningitis and discusses viral causes, but does not say that viral meningitis is the most common type of aseptic meningitis. Page numbers are unavailable in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn the United Arab Emirates between 2000 and 2005, 37% of meningitis cases were viral, with a mortality rate of 3%, and children and young adults were the most affected age group.
“Based on earlier studies in the Gulf region between 2000 and 2005, 37% of meningitis cases in the United Arab Emirates (UAE) were caused by viral infections, with a mortality rate of 3%. The same study also showed that children and young adults are the most affected age group [15].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [15] Dash N et al (2007) Epidemiology of meningitis in Al-Ain, United Arab Emirates, 2000–2005. Int J Infect Dis 11(4):309–312 source
The Abstract and Results report that 37% of 92 meningitis cases in Al-Ain Medical District were viral; the Results give a 3% case-fatality rate for viral meningitis. The claim extends this district-level finding to the UAE as a whole. The Results say viral cases occurred mainly among children and young adults, but the highest rate of meningitis overall was in children aged 0–5, not children and young adults collectively. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn Kuwait, 387 patients, mainly pediatric, had aseptic meningitis, with echovirus 9, E-11, and E-30 accounting for 24% of cases.
“In another study from Kuwait, it was shown that 387 patients (mainly pediatric patients) had aseptic meningitis, with the most common viral agents being echovirus 9 (E-9), E-11 and E-30, accounting for 24% of the cases [16].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [16] Dalwai A, Ahmad S, Al-Nakib W (2010) Echoviruses are a major cause of aseptic meningitis in infants and young children in Kuwait. Virol J 7(1):236 source
The Patient’s data section reports 387 children under 12 with aseptic meningitis, and Table 3 identifies E9, E11 and E30 as the most common detected enterovirus genotypes. But the Abstract’s Results assign 24% to all enterovirus-positive cases (92 of 387), not to those three echoviruses. Table 3 lists 60 cases with those genotypes, about 16% of the 387 cases. (LLM, conf=0.93)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn England between 2011 and 2014, the incidence of viral meningitis was 2.73 per 100,000, with most cases caused by non-polio enteroviruses.
“A study conducted in England between 2011 and 2014 showed that the incidence of viral meningitis was 2.73 per 100,000, with the largest number of cases caused by non-polio enteroviruses [8].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [8] McGill F et al (2018) Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study. Lancet Infect Dis 18(9):992–1003 source
The Results report enrollment across England from September 2011 to September 2014 and identify enteroviruses as the most frequent cause of confirmed viral meningitis (127 of 231 cases). The Discussion gives an estimated annual incidence of 2.73 per 100,000, but specifies UK adults with confirmed viral meningitis; it does not identify the enteroviruses as non-polio. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn Lebanon, 82.7% of study subjects were diagnosed with viral meningitis and 17.3% with bacterial meningitis.
“Furthermore, a study in Lebanon showed that 82.7% of study subjects were diagnosed with viral meningitis, while only 17.3% were diagnosed with bacterial meningitis [22].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [22] Haydar SM et al (2019) Adherence to international guidelines for the treatment of meningitis infections in Lebanon. Saudi Med J 40(3):260–265 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationViral meningitis occurs throughout the year but is most common in summer and autumn.
“Viral meningitis occurs throughout the year, but it is most commonly seen in summer and autumn [7].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [7] Logan SAE, MacMahon E (2008b) Viral meningitis. BMJ (Clinical research ed.) 336(7634):36–40 source
The “Who gets it?” section says enterovirus infection is highest in summer and autumn in temperate climates, but remains high year-round in tropical and subtropical climates. Enteroviruses are the most common cause of viral meningitis, yet the paper does not state that viral meningitis overall follows this year-round pattern or that its summer–autumn peak applies across climates. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThe SARS-CoV-2 case report suggests that SARS-CoV-2 may be neuroinvasive and may cause central nervous system complications such as meningitis.
“This case report indicates the possible neuroinvasive potential of SARS-CoV-2 and its potential to cause CNS complications such as meningitis [14] (Tables 1 and 2).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [14] Moriguchi T et al (2020) A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis 94:55–58 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAccording to the Palestinian Ministry of Health, aseptic meningitis incidence is 6.8 per 100,000 in the West Bank and 247 per 100,000 in the Gaza Strip.
“According to the Palestinian Ministry of Health, the incidence of aseptic meningitis is 6.8 per 100,000 in the West Bank and 247 per 100,000 in the Gaza Strip [21].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [21] Dumaidi K, Al-Jawabreh A (2017) Molecular detection and genotyping of enteroviruses from CSF samples of patients with suspected sepsis-like illness and/or aseptic meningitis from 2012 to 2015 in West Bank, Palestine. PLoS ONE 12(2):e0172357–e0172357 source
The Introduction reports the same rates for the West Bank and Gaza Strip in 2014, and the Discussion figure caption identifies the incidence data as Ministry of Health-reported. But the source describes the rates as covering “sepsis-like illness and/or viral meningitis,” not aseptic meningitis alone. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEnterovirus infection can lead to different clinical outcomes, including respiratory illness, hepatitis, pancreatitis, myocarditis, and hand, foot, and mouth disease.
“Infection with EVs can lead to different clinical outcomes, such as respiratory illness, hepatitis, pancreatitis, myocarditis, and hand, foot, and mouth (HFM) disease [52, 53].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [52] Wells AI, Coyne CB (2019) Enteroviruses: a gut-wrenching game of entry, detection, and evasion. Viruses 11(5):460 source
- cites [53] Akuzawa N et al (2014) Myocarditis, hepatitis, and pancreatitis in a patient with coxsackievirus A4 infection: a case report. Virol J 11:3–3 source
The Background and Discussion identify coxsackieviruses as enteroviruses associated with myocarditis and pancreatitis; the Case report describes liver dysfunction in a patient with coxsackievirus A4 infection. The Case report also mentions earlier cough and sore throat, but does not establish respiratory illness as an enterovirus outcome, and our copy does not address hand, foot, and mouth disease. No page numbers are available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationOther manifestations of meningitis include short and fast breathing, loss of appetite, neck stiffness and pain, and sensitivity to bright light.
“Other manifestations of the disease include short and fast breathing, loss of appetite, neck stiffness and pain, and sensitivity to bright light [28].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [28] Parikh V, Tucci V, Galwankar S (2012) Infections of the nervous system. Int J Crit Illn Inj Sci 2(2):82 source
The Meningitis > Neisseria meningitides section (page unavailable) lists a stiff neck and radicular pain; the Listeria section also reports poor feeding, but specifically in infants. The St. Louis encephalitis section lists photophobia with a viral meningitis presentation. Our copy does not identify short, fast breathing as a meningitis manifestation, and its support for loss of appetite is limited to infant poor feeding. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationChildren are usually less likely to present with meningeal complications and often present with nonspecific illness, making meningitis more likely to be misdiagnosed in children.
“Children are usually less likely to present with meningeal complications and usually present with nonspecific illness, which makes meningitis more likely to be misdiagnosed in children [31].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [31] Shukla B et al (2017) Aseptic meningitis in adults and children: diagnostic and management challenges. J Clin Virol 94:110–114 source
The Discussion (page unavailable) says children in this aseptic-meningitis cohort were less likely than adults to present with meningeal complaints and notes that children often present with nonspecific febrile illness. Neither the Discussion nor the Results (page unavailable) establishes that meningitis is more likely to be misdiagnosed in children; the paper's diagnostic-challenge conclusion concerns unknown etiologies, not a higher pediatric misdiagnosis rate. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMost viral meningitis cases go undetected, and fatal cases manifest as severe encephalitic syndrome rather than meningitis.
“Moreover, it is made harder by the fact that most viral meningitis cases go undetected, and fatal cases manifest as severe encephalitic syndrome rather than meningitis [29].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Irani DN (2008) Aseptic meningitis and viral myelitis. Neurol Clin 26(3):635 source
The Clinical Features section (page not supplied) reports that some viral infections with a more encephalitic presentation have adverse outcomes, while aseptic meningitis is typically self-limited. It does not establish that fatal cases generally present as severe encephalitis, or that most viral meningitis cases go undetected. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationNext-generation sequencing has been used in studies to detect a wide variety of pathogens including viruses, but its possible application as a diagnostic tool in meningitis is not yet clear.
“Next-generation sequencing (NGS) was recently used in a number of studies to detect a wide variety of pathogens, including viruses, the possible application of this technique as a diagnostic tool in meningitis cases is not yet clear, and more studies are required [45].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [45] Poplin V, Boulware DR, Bahr NC (2020) Methods for rapid diagnosis of meningitis etiology in adults. Biomark Med 14(6):459–479. https://doi.org/10.2217/bmm-2019-0333 source
May combine two claims.
PremisecitationEV-D68 strains were able to infect and replicate in a human neuroblastoma cell line and a postnatal cortical neuron culture, whereas non-neurotropic strains were not.
“In addition, EV-D68 strains were able to infect and replicate in a human neuroblastoma cell line and a postnatal cortical neuron culture, but non-neurotropic strains were not [60].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [60] Brown DM et al (2018) Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells. mBio 9(5):e01954-e2018 source
The Results report that US/MO/47 replicated in the SH-SY5Y neuroblastoma cell line and primary human neurons, whereas US/TN and VR1197 did not. Materials and Methods identifies the latter culture as human postnatal brain neurons, but our copy does not identify them as cortical neurons. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationEchoviruses such as E-6, E-9, E-11, E-13, E-19, and E-30 belong to the species Enterovirus B and are commonly associated with viral meningitis in children.
“Echoviruses, such as E-6, E-9, E-11, E-13, E-19, and E-30 also belong to the species Enterovirus B and are commonly known to be associated with viral meningitis in children [69].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [69] Kim H-J et al (2012) Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008. Virol J 9:38–38. https://doi.org/10.1186/1743-422X-9-38 source
May combine two claims.
PremisecitationNeutrophilic pleocytosis usually indicates bacterial rather than viral meningitis, but 25% of patients with central nervous system abnormalities caused by viral agents have neutrophilic pleocytosis.
“The presence of neutrophilic pleocytosis is usually indicative of bacterial meningitis rather than viral meningitis. However, it has been found that 25% of patients with CNS abnormalities caused by viral agents have neutrophilic pleocytosis [39].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [39] Jaijakul S et al (2017) The clinical significance of neutrophilic pleocytosis in cerebrospinal fluid in patients with viral central nervous system infections. Int J Infect Dis 59:77–81 source
May combine two claims.
PremisecitationIn viral meningitis, the WBC count typically ranges from 80 to 100 cells/μl with a large proportion of lymphocytes (>80%), and glucose and protein levels usually remain normal.
“In viral meningitis, the WBC count typically ranges between 80 and 100 cells/μl (pleocytosis), with a large proportion of lymphocytes (>80%) [21]. Also, glucose and protein levels usually remain normal [35].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [21] Dumaidi K, Al-Jawabreh A (2017) Molecular detection and genotyping of enteroviruses from CSF samples of patients with suspected sepsis-like illness and/or aseptic meningitis from 2012 to 2015 in West Bank, Palestine. PLoS ONE 12(2):e0172357–e0172357 source
The Introduction (page not provided) describes CSF pleocytosis as a feature of aseptic meningitis, supporting that limited part of the cited clause. It gives age-dependent WBC thresholds, not a typical count of 80–100 cells/μl, and does not report lymphocytes exceeding 80%. The Results (page not provided) also report that many enterovirus-positive patients lacked pleocytosis. The separate statement about glucose and protein cites [35], not this source. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [35] Seehusen DA, Reeves M, Fomin D (2003) Cerebrospinal fluid analysis. Am Fam Physician 68(6):1103–1108
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationGram staining and bacterial culture are key diagnostic tools for identifying bacterial infections, and viral meningitis is suspected when both are negative.
“Gram staining and bacterial culture are the key diagnostic tools for identifying bacterial infections [2], and viral meningitis is suspected when Gram staining and culture of CSF are negative.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [2] Hoffman O, Weber JR (2009) Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord 2(6):401–412 source
May combine two claims.
PremisecitationViral meningitis pathogenesis begins when the causative agent enters the host through respiratory secretions or the fecal-oral route, causing primary infection in the respiratory or gastrointestinal tract, followed by secondary central nervous system infection that causes meningitis or other neurological problems.
“The pathogenesis of viral meningitis begins when the causative agent enters the host through respiratory secretions or by the fecal-oral route to cause primary infection in the respiratory or gastrointestinal (GI) tract. This is followed by secondary infection of the CNS, causing meningitis or other neurological problems.”
Quote in the paperNot a substantial claim2 of 4 sources checked- cites [46] Kim JV et al (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457(7226):191–195 source
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [47] Wolinsky JS, Klassen T, Baringer JR (1976) Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis 133(3):260–267 source
- cites [48] Wong KT et al (2008) The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol 67(2):162–169 source
- cites [49] Munster VJ et al (2012) Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Sci Rep 2(1):736 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDifficulty focusing or concentrating and double vision can be associated with meningitis and may continue after recovery.
“In addition, difficulty in focusing or concentrating as well as double vision can also be associated with meningitis and may continue after recovery [29].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Irani DN (2008) Aseptic meningitis and viral myelitis. Neurol Clin 26(3):635 source
The Aseptic Meningitis Clinical Features section says that symptoms in adults with enteroviral meningitis may persist for several weeks. It does not identify difficulty concentrating or double vision, or say that either continues after recovery. Searches for focusing, concentration, double vision, and diplopia found no passage addressing those symptoms. (LLM, conf=0.73)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationRisk factors that increase susceptibility to viral meningitis include compromised immunity, age, travel history, and HIV infection.
“There are a number of risk factors that are known to increase one's susceptibility to contracting viral meningitis, including compromised immunity, age, travel history, and HIV infection [7].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [7] Logan SAE, MacMahon E (2008b) Viral meningitis. BMJ (Clinical research ed.) 336(7634):36–40 source
“How common is viral meningitis?” reports that incidence is highest in young children, and “What causes it?” (box 1) links immunocompromised hosts and travel history to particular viral causes. The “Human immunodeficiency virus” section identifies primary HIV infection as a cause of aseptic meningitis. The paper does not establish that all four factors generally increase susceptibility to contracting viral meningitis; travel history, in particular, is presented as a clue to the possible cause of an existing case. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationViral infection of the central nervous system can occur through infection of the choroid plexus epithelium, infection of lymphoid tissue, induction of inflammation and blood-brain barrier breakdown, and infection of peripheral sensory neural pathways.
“Viral infection of the CNS can occur through different mechanisms, such as infection of the choroid plexus epithelium, infection of the lymphoid tissue, induction of inflammation and blood-brain barrier (BBB) breakdown, and infection of peripheral sensory neural pathways [46–49] (Fig. 1).”
Quote in the paperNot a substantial claim2 of 4 sources checked- cites [46] Kim JV et al (2009) Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 457(7226):191–195 source
The main text reports blood–brain barrier breakdown and inflammatory cell recruitment during LCMV infection of the murine CNS. But the Methods (Virus; page unavailable) say the mice were infected intracerebrally, and the paper treats barrier breakdown as injury following infection—not as a route by which virus enters the CNS. Our copy does not support the listed choroid plexus, lymphoid-tissue, or sensory-neural pathways. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [47] Wolinsky JS, Klassen T, Baringer JR (1976) Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis 133(3):260–267 source
- cites [48] Wong KT et al (2008) The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol 67(2):162–169 source
- cites [49] Munster VJ et al (2012) Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route. Sci Rep 2(1):736 source
The Results (Entry of Nipah virus into the CNS) directly document entry along olfactory neurons, supporting the peripheral sensory neural pathway. The Discussion describes blood–brain barrier disruption as a proposed route but says it was unlikely to be the initial route in these hamsters; it also discusses inflammation as a possible cause of barrier breakdown, not as a demonstrated entry mechanism. Our copy does not describe CNS entry through infection of the choroid plexus epithelium or lymphoid tissue. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationFour glycoproteins in HSV-1 and HSV-2 are important for viral entry (gB, gD, gH, and gL), but cell binding is mediated by only two glycoproteins, gB and/or gC, that bind to cell-surface heparan sulfate.
“Four glycoproteins in HSV-1 and HSV-2 are important for viral entry (gB, gD, gH, and gL); however, cell binding is mediated by only two glycoproteins, gB and/or gC, that bind to cell-surface heparan sulfate [82].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Spear PG, Longnecker R (2003) Herpesvirus entry: an update. J Virol 77(19):10179–10185 source
May combine two claims.
PremisecitationEBV can infect endothelial cells of blood vessels in the brain, causing latent infection; when the brain undergoes stress, the virus can be activated and expression of cytokines and chemokines such as IL-1, TNF-α, IL-12, and IL18 increases, resulting in an inflammatory response.
“The virus can also infect the endothelial cells of blood vessels in the brain, causing latent infection. When the brain undergoes stress, the virus can be activated and the expression of different cytokines and chemokines, such as IL-1, TNF-α, IL-12 and IL18 increases, resulting in an inflammatory response [86].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [86] Koyuncu OO, Hogue IB, Enquist LW (2013) Virus infections in the nervous system. Cell Host Microbe 13(4):379–393. https://doi.org/10.1016/j.chom.2013.03.010 source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationEV-D68 is the most common member of the species Enterovirus D associated with aseptic meningitis and can cause central nervous system complications in children, commonly meningitis and flaccid paralysis.
“Enterovirus D68 (EV-D68) is the most common member of the species Enterovirus D found to be associated with the development of aseptic meningitis. EV-D68 can cause CNS complications in children, commonly meningitis and flaccid paralysis [72].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [72] González-Sanz R et al (2019) Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018. Emerg Microbes Infect 8(1):1438–1444 source
The non-respiratory-disease results (p. 4) report EV-D68 in children with meningitis or meningoencephalitis and acute flaccid paralysis. But the paper calls EV-D68 the most frequently detected enterovirus in its respiratory samples (Abstract, p. 2), not the most common member of species Enterovirus D associated with aseptic meningitis. The Discussion (p. 7) also says the association with paralysis is accepted but causality has not been proven, so “can cause” is stronger than its conclusion. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationValacyclovir was tested in clinical trials for antiviral suppression of recurrence of meningitis, but treatment with valacyclovir twice daily did not prevent recurrent meningitis and was not recommended for this purpose.
“Valacyclovir was also tested in clinical trials for its antiviral suppression ability on recurrence of meningitis. However, treatment with valacyclovir (twice daily) did not prevent recurrent meningitis and was not recommended for this purpose [105, 106].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [105] Aurelius E et al (2012) Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial. Clin Infect Dis 54(9):1304–1313 source
- cites [106] Kato K et al (2015) Recurrent neonatal herpes simplex virus infection with central nervous system disease after completion of a 6-month course of suppressive therapy: case report. J Infect Chemother 21(12):879–881 source
May combine two claims.
PremisecitationPsoromic acid, a bioactive lichen-derived compound, has been found to inhibit replication of both HSV-1 and HSV-2 by inhibiting proteases and DNA polymerases, making it a possible drug for treating meningitis caused by HSV.
“Recently, a promising drug called psoromic acid (a bioactive lichen-derived compound) has been found to inhibit the replication of both HSV-1 and HSV-2 by inhibiting proteases and DNA polymerases, which makes it a possible drug for treating meningitis caused by HSV [104].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [104] Hassan STS et al (2019) Psoromic acid, a lichen-derived molecule, inhibits the replication of HSV-1 and HSV-2, and inactivates HSV-1 DNA polymerase: shedding light on antiherpetic properties. Molecules (Basel, Switzerland) 24(16):2912 source
Results and Discussion §2.1 reports that psoromic acid inhibits HSV-1 and HSV-2 replication, and §2.2 links its anti-HSV-1 activity to inhibition of HSV-1 DNA polymerase. Section 2.4 suggests HSV-2 protease inhibition from molecular docking, rather than demonstrating that protease inhibition causes reduced replication. The paper does not assess psoromic acid as a treatment for HSV meningitis. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationInfection of the central nervous system by West Nile virus activates Toll-like receptor 3, increases the concentration of TNF-α and other pro-inflammatory factors, which in turn increases the permeability of the blood-brain barrier and leads to neural death.
“Infection of the CNS by WNV activates Toll-like receptor 3, increases the concentration of TNF-α and other pro-inflammatory factors, which in turn increases the permeability of the BBB and leads to neural death [96].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [96] Lim SM et al (2011b) West Nile virus: immunity and pathogenesis. Viruses 3(6):811–828 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA recent systematic analysis showed that most viral meningitis cases have a good long-term clinical outcome and that patients with viral meningitis have a better outcome after hospital discharge than patients with viral encephalitis.
“A recent systematic analysis showed that most viral meningitis cases have a good long-term clinical outcome and that patients with viral meningitis have a better outcome after hospital discharge than patients with viral encephalitis [109].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [109] Hudson JA et al (2020) Outcomes beyond hospital discharge in infants and children with viral meningitis: a systematic review. Rev Med Virol 30(2):e2083 source
The Discussion reports good clinical outcomes in the majority of cases, but the review covers infants and children, not patients of all ages. It also says its results “suggest” children with viral meningitis “may have better outcomes” than children with viral encephalitis; the citing sentence presents that comparison as established. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationEBV pathogenesis starts when the virus infects oropharyngeal epithelium cells, then spreads to lymphoid tissue and infects lymphoid cells, mainly B cells; in the infected B cell population the virus can be latent or, less frequently, lytic, and in the latent stage it mainly expresses EBNAs and LMPs.
“EBV pathogenesis starts when the virus infects oropharyngeal epithelium cells. It then spreads to the lymphoid tissue and infects lymphoid cells, mainly B cells. In the infected B cell population, the virus can be latent or, less frequently, lytic. In the latent stage, the virus mainly expresses EBNAs (Epstein-Barr nuclear antigens) and LMPs (latent membrane proteins) [85].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [85] Akkoc G et al (2016) Epstein-Barr virus encephalitis in an immunocompetent child: a case report and management of Epstein-Barr virus encephalitis. Case Rep Infect Dis 2016 source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThese herpesviruses are known to cause meningitis and can establish a latent infection in neurons that can be reactivated.
“All of these viruses are known to cause meningitis and can establish a latent infection in neurons, which can be reactivated [82].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Spear PG, Longnecker R (2003) Herpesvirus entry: an update. J Virol 77(19):10179–10185 source
The opening section says HSV-1 and HSV-2 can cause meningitis and that they, along with VZV, establish latent infections in neurons and can reactivate from neurons. It does not say VZV causes meningitis, so the claim's 'all of these viruses' wording is not fully supported. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationHuman influenza viruses often cause pneumonia and acute respiratory distress syndrome, but on rare occasions they can cause extra-respiratory illnesses including meningitis, encephalitis, meningoencephalitis, and myelitis.
“Human influenza viruses often cause pneumonia and acute respiratory distress syndrome (ARDS) [87], but on rare occasions, they can cause extra-respiratory illnesses, including meningitis [87], encephalitis [88], meningoencephalitis, and myelitis [89].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [87] Liang C-Y, Yang C-H, Lin J-N (2018) Focal encephalitis, meningitis, and acute respiratory distress syndrome associated with influenza A infection. Med Princ Pract 27(2):193–196 source
The Introduction lists pneumonia and meningitis among influenza complications, and the Conclusion says neurologic complications are infrequent compared with respiratory symptoms. The Conclusion also reports one patient with acute respiratory distress syndrome (ARDS), but the paper does not establish that influenza often causes ARDS; a single case cannot support that frequency claim. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [88] Sejvar JJ, Uyeki TM (2010) Neurologic complications of 2009 influenza A (H1N1). Neurology 74(13):1020 source
- cites [89] Xia J-B et al (2014) H7N9 influenza A-induced pneumonia associated with acute myelitis in an adult. Intern Med 53(10):1093–1095 source
Citation [89] follows “meningoencephalitis, and myelitis.” The Introduction says influenza-associated nervous-system symptoms are uncommon and lists myelitis among reported complications; the Abstract describes a patient with H7N9-associated acute myelitis. Our copy does not mention meningoencephalitis, so that part of the attributed claim is unsupported. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationBecause HVEM is present on various cell types including epithelial cells and neurons, viral entry through this receptor is suggested in meningitis.
“HVEM is present on the surface of various cell types, including epithelial cells and neurons. Accordingly, viral entry through this receptor is suggested in meningitis.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Spear PG, Longnecker R (2003) Herpesvirus entry: an update. J Virol 77(19):10179–10185 source
The HSV entry section (page not specified) identifies HVEM as an entry receptor and says it is expressed in various cell types, including epithelial cells. It attributes neuronal expression and potential entry into neurons to nectins, not HVEM, and does not suggest HVEM-mediated entry in meningitis. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThree known cellular receptors have been identified for HSV: herpesvirus entry mediator, members of the immunoglobulin superfamily, and heparan sulfate generated by certain isoforms of 3-O-sulfotransferases.
“Three known cellular receptors have been identified for HSV: 1) herpesvirus entry mediator (HVEM), 2) members of the immunoglobulin superfamily, and 3) heparan sulfate generated by certain isoforms of 3-O-sulfotransferases [82].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [82] Spear PG, Longnecker R (2003) Herpesvirus entry: an update. J Virol 77(19):10179–10185 source
May combine two claims.
PremisecitationThe pathogenesis of West Nile virus depends mainly on replication of virus in the host's lymph nodes and skin keratinocytes, resulting in primary viremia; the virus can then spread to secondary locations such as the central nervous system after penetrating the blood-brain barrier.
“The pathogenesis of the virus depends mainly on the replication of virus in the host's lymph nodes and skin keratinocytes [95], resulting in primary viremia. The virus can then spread to secondary locations such as CNS after penetrating the BBB [96].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [95] Lim P-Y et al (2011a) Keratinocytes are cell targets of West Nile virus in vivo. J Virol 85(10):5197–5201 source
- cites [96] Lim SM et al (2011b) West Nile virus: immunity and pathogenesis. Viruses 3(6):811–828 source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome vaccines have been developed for viruses such as EV-71.
“Some vaccines have been developed for some viruses such as EV-71 [107], considering its clinical significance, and the different types of EV-71 vaccines are summarized in Table 4.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [107] Yi E-J et al (2017) Enterovirus 71 infection and vaccines. Clin Exp Vaccine Res 6(1):4–14 source
May combine two claims.
PremisecitationE-30 can cause neural damage by modulating TRIO protein function: it affects guanine exchange factor domain 2, activating RhoA, which activates ROCK and MLC signaling pathways, leading to actin formation and elevated nitric oxide levels, resulting in central nervous system complications.
“E-30 can cause neural damage by modulating the function of the TRIO protein. In the first pathway, the virus affects the function of guanine exchange factor domain 2 (GEFD2), which results in the activation of Ras homology family member A (RhoA), a GTPase signaling protein. This activates both the ROCK and MLC signaling pathways. This cascade of events leads to actin formation and elevation of the”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [71] Lee J-W et al (2012) Echovirus 30 induced neuronal cell death through TRIO-RhoA signaling activation. PLoS ONE 7(5):e36656–e36656 source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationV-7404 (a viral polymerase inhibitor) and DAS181 (a sialidase) are newly developed drugs against EV-D68.
“Moreover, V-7404 (viral polymerase inhibitor) and DAS181 (sialidase) are newly developed drugs against EV-D68 [73, 76].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [73] Esposito S et al (2015) Enterovirus D68 infection. Viruses 7(11):6043–6050 source
Section 5 (Diagnosis, Treatment and Prevention; page not provided) reports strong inhibitory activity against EV-D68 for both compounds and identifies DAS181 as a sialidase fusion protein. But it calls V-7404 a protease inhibitor, not a polymerase inhibitor, and says the drugs are being developed for other infections while remaining possible candidates for EV-D68 outbreaks. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [76] Messacar K et al (2018) Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Lancet Infect Dis 18(8):e239–e247 source
The Introduction (page unavailable) calls for further research to inform treatment, but does not identify V-7404 or DAS181 as drugs against EV-D68. Searches for both drug names and their proposed roles found no passage addressing the claim. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn Jordan, viral meningitis accounted for 83% of all meningitis cases between 2001 and 2004 and 81% in 2014.
“Moreover, higher percentages of viral meningitis were reported in Jordan, reaching 83% of all meningitis cases between 2001 and 2004, and 81% in 2014 [19].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Alzein K (2016) Revision of meningitis surveillance system in Jordan during 2001 and 2014 years. Epidemiol (sunnyvale) 6:220. https://doi.org/10.4172/2161-1165.100022 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenThe pathogenesis of viral meningitis is not clearly defined.
“The pathogenesis of viral meningitis is not clearly defined, and more studies are needed to improve the health care of patients in terms of early diagnosis and management.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn Gaza during 2013-2014, 72% of meningitis cases were viral, mainly caused by enterovirus infection (35%).
“In a two-year study in Gaza (2013–2014), 72% of meningitis cases were classified as viral meningitis, caused mainly by an EV infection (35%) [20].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Ghuneim N, Dheir M, AbuAli K (2016) Epidemiology of different types of meningitis cases in gaza governorates, occupied Palestinian Territory, December 2013–January 2014. J Antivir Antiretrovir 8(1):26–34 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn Denmark, non-polio enteroviruses were the most common causative agent of aseptic meningitis, and incidence decreased with age from 58.7 per 100,000 after birth to 38.7 per 100,000 at 6 months and 15.6 per 100,000 at 5 years.
“In addition, a study done in Denmark showed similar findings, with non-polio enteroviruses being the most common causative agent. They also showed that the incidence of aseptic meningitis decreases with increasing age (58.7 per 100,000 after birth, 38.7 per 100,000 in 6-month-old infants, and 15.6 per 100,000 in 5-year-old children) [10] (Table 1).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] Hviid A, Melbye M (2007) The epidemiology of viral meningitis hospitalization in childhood. Epidemiology 18(6):695–701 source
May combine two claims.
PremisecitationIn Austria from 2001 to 2004, 56% of study patients had viral meningitis, with E-30, coxsackievirus-B, and EV-71 being the most frequent viruses.
“In Austria (2001-2004), 56% of the patients included in a study had viral meningitis, where E-30 (36.4%), coxsackievirus-B (19.6%), and EV-71 (13.1%) were the viruses that were most frequently found [13].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Ortner B et al (2009) Epidemiology of enterovirus types causing neurological disease in Austria 1999–2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol 81(2):317–324 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn China, viral meningitis caused by EV-71 accounted for about 55.2% of neurological disorders.
“Also, a study conducted in China found that viral meningitis caused by EV-71 accounted for approximately 55.2% of neurological disorders [11].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [11] Hu Y, Jiang L, Peng H-L (2015) Clinical analysis of 134 children with nervous system damage caused by enterovirus 71 infection. Pediatr Infect Dis J 34(7):718–723 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn Egypt, among 250 confirmed meningitis cases, 17 were caused by viral agents, most commonly EV, HSV, and VZV.
“In Egypt, out of 250 confirmed cases of meningitis, 17 were caused by viral agents, and the most commonly encountered viruses were EV, herpes simplex virus (HSV), and varicella zoster virus (VZV) [23].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] Selim HS et al (2007) Microbial study of meningitis and encephalitis cases. J Egypt Public Health Assoc 82(1–2):1–19
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIn Qatar, the incidence of viral meningitis from 2011 to 2015 was estimated at 6.4 per 100,000, with most cases being children infected with enterovirus.
“In Qatar, it has been estimated that the incidence of viral meningitis from 2011 to 2015 was 6.4 per 100,000, with most cases being children infected with EV [17].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [17] Abid FB et al (2018) Epidemiology and clinical outcomes of viral central nervous system infections. Int J Infect Dis 73:85–90 source
May combine two claims.
Interpretationnone givenClinical manifestations and symptoms of viral meningitis are largely similar across causative agents, which makes early diagnosis difficult.
“With few exceptions, the clinical manifestations and symptoms associated with viral meningitis are similar for the different causative agents, which makes it difficult to diagnose the disease at early stages.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCoxsackievirus replicates in monocytes, T cells, and B cells during the viremia phase, and the susceptibility of immune cells to infection determines the severity of secondary organ damage.
“Another study demonstrated that this virus replicates in monocytes, T cells, and B cells during the viremia phase and that the level of susceptibility of immune cells to infection determines the severity of secondary organ damage [67], such as causing severe meningitis after reaching the CNS.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Hwang JY et al (2012) Characterization of infections of human leukocytes by non-polio enteroviruses. Intervirology 55(5):333–341 source
May combine two claims.
PremisecitationPatients with meningitis usually suffer from fever, chills, abdominal pain, nausea, and headache.
“Patients with meningitis usually suffer from fever, chills, abdominal pain, nausea, and headache [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Kumar R (2005) Aseptic meningitis: diagnosis and management. Indian J Pediatr 72(1):57–63 source
May combine two claims.
PremisecitationAnalysis of brain tissues from mice born to mothers inoculated with coxsackievirus B4 showed signs of meningitis, accumulation of immune cells mainly T cells, and increased secretion of inflammatory cytokines and chemokines.
“Moreover, analysis of brain tissues obtained from mice born to mothers inoculated with coxsackievirus B4 showed signs of meningitis and accumulation of immune cells (mainly T cells) and increased secretion of inflammatory cytokines and chemokines (IL6, TNF-α, IFNα and MCP-1) [68].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [68] Jmii H et al (2020) Immunopathology in the brain of mice following vertical transmission of Coxsackievirus B4. Microb Pathog 103965 source
May combine two claims.
PremisecitationJolt accentuation of headache can be used in emergency settings to exclude meningitis, but its pooled sensitivity of 65.3% and specificity of 70.4% are considered low.
“A systematic review done by Iguchi and colleagues showed that jolt accentuation can be used in emergency settings to exclude meningitis. However, the pooled sensitivity and specificity of this test (65.3%, 70.4% respectively) are considered low, and more research is needed to assess its usefulness [32].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Iguchi M et al (2020) Diagnostic test accuracy of jolt accentuation for headache in acute meningitis in the emergency setting. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD012824 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationEnteroviruses can undergo vertical transmission from an infected mother to her infant by crossing the placenta or through breastfeeding.
“They can also undergo vertical transmission from an infected mother to her infant by crossing the placenta or through breastfeeding [55].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [55] Mereaux J et al (2017) Enterovirus infection during pregnancy: Underestimated cause of fetal and neonatal complications? Gynecologie, obstetrique, fertilite & senologie 45(4):231–237 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenThe pathogenesis of aseptic meningitis is not well understood and is difficult to study because of limited data.
“However, the pathogenesis of aseptic meningitis is not well understood, and it is difficult to study due to limited data.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationDiagnosis of mumps virus, herpesvirus, arboviruses, and HIV infections can be achieved using serological assays, but results might be negative at early stages, so a second sample should be obtained after two weeks and tested again.
“On the other hand, diagnosis of mumps virus, herpesvirus, arboviruses, and human immunodeficiency virus (HIV) infections can be achieved using serological assays, although the results might be negative at early stages of the disease. Hence, a second sample should be obtained after two weeks and tested again for the presence of viral agents [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Kumar R (2005) Aseptic meningitis: diagnosis and management. Indian J Pediatr 72(1):57–63 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEnteroviruses can be transmitted through respiratory secretions or by the fecal-oral route.
“Enteroviruses can be transmitted through respiratory secretions or by the fecal-oral route [54].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Burrell CJ, Howard CR, Murphy FA (2017) Chapter 32—picornaviruses. In: Burrell CJ, Howard CR, Murphy FA (eds) Fenner and White’s Medical virology (Fifth Edition). Academic, London, pp 447–463 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSkin rash is observed with certain types of meningitis and is considered a late sign of bacterial meningitis, where the pathogen in the blood targets capillary cells and damages them.
“Skin rash is also observed with certain types of meningitis and is considered a late sign of bacterial meningitis, where the pathogen in the blood targets the capillary cells, leading to their damage [30].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Tsai J, Nagel MA, Gilden D (2013) Skin rash in meningitis and meningoencephalitis. Neurology 80(19):1808–1811 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBecause obtaining CSF is difficult, alternative specimens such as blood, throat or nasal swabs, or stool samples might be used, particularly in suspected EV infections.
“However, since obtaining CSF is difficult, alternative specimens, such as blood, throat or nasal swabs, or stool samples might be used instead, particularly in cases of suspected EV infections [44].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Kupila L et al (2005) Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. Clin Infect Dis 40(7):982–987 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA case report diagnosed a 9-day-old newborn with EV E-25 viral meningitis using RT-PCR and sequencing.
“A recent case report described a 9-day-old newborn admitted to the emergency department with nonspecific symptoms of fever and irritability. Molecular analysis (RT-PCR and sequencing) showed that the patient was positive for EV (specifically, E-25) and viral meningitis was diagnosed [43].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Alhazmi A et al (2020) Repeated viral meningitis in a newborn. J NeuroVirol 1–3 source
May combine two claims.
PremisecitationThe virus can reach the bloodstream by infecting immune cells and cause secondary infections at other sites, such as the heart and central nervous system.
“Also, the virus could reach the bloodstream by infecting immune cells and cause secondary infections at other sites, such as the heart and CNS [61].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [61] Palacios G, Oberste M (2005) Enteroviruses as agents of emerging infectious diseases. J Neurovirol 11(5):424–433 source
May combine two claims.
PremisecitationIn most cases, enterovirus enters through the oral-fecal route, reaches the lower gastrointestinal tract, binds to a receptor on enterocytes, crosses the intestinal lining, reaches Peyer's patches, and continues replication.
“In most cases, the virus enters the body through the oral-fecal route until it reaches the lower gastrointestinal (GI) tract, where it binds to a specific receptor on the surface of enterocytes and crosses the lining of the intestine, reaching the Peyer’s patches, where it continues its replication [57].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [57] Rotbart HA (2000) Viral meningitis. In: Seminars in neurology. Copyright© 2000 by Thieme Medical Publishers, Inc source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn Egypt, 56% of pediatric aseptic meningitis cases were due to enterovirus.
“Another study in Egypt done on pediatric patients with aseptic meningitis found that 56% of cases were due to EV [24].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Shaker OG, Abdelhamid N (2015) Detection of enteroviruses in pediatric patients with aseptic meningitis. Clin Neurol Neurosurg 129:67–71 source
May combine two claims.
PremisecitationIn HPeV-positive meningitis cases, RT-PCR achieved 100% sensitivity while viral culture failed to detect the virus.
“Similarly, in a study of HPeV-positive meningitis cases, 100% sensitivity was achieved with RT-PCR, while viral culture failed to detect the virus [42].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [42] De Crom S et al (2013) Prospective comparison of the detection rates of human enterovirus and parechovirus RT-qPCR and viral culture in different pediatric specimens. J Clin Virol 58(2):449–454 source
May combine two claims.
PremisecitationMeningitis symptoms can resemble those of encephalitis or brain abscess, so viral meningitis can be misdiagnosed.
“In fact, signs and symptoms of meningitis can be similar to those of other diseases such as encephalitis or brain abscesses, and hence, viral meningitis can be misdiagnosed [25].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25] Visintin C et al (2010) Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance. BMJ 340:c3209 source
May combine two claims.
PremisecitationPleocytosis is generally considered an important criterion for diagnosing viral meningitis, but it is often not observed in EV meningitis cases involving infants (38%) or children (39%), or when lumbar puncture is performed early.
“Pleocytosis generally is considered an important criterion for diagnosis of viral meningitis. However, a number of studies have shown that pleocytosis is often not observed in EV meningitis cases involving infants (38%) or children (39%), or when a lumbar puncture is performed at an early stage of disease [36, 37].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] de Crom SC et al (2012) Characteristics of pediatric patients with enterovirus meningitis and no cerebral fluid pleocytosis. Eur J Pediatr 171(5):795–800 source
- cites [37] Alhazmi A et al (2019) Paediatric enterovirus meningitis without cerebrospinal fluid pleocytosis. J Infect 79(6):612–625 source
May combine two claims.
InterpretationreasoningA strong inflammatory immune response is induced during aseptic meningitis and plays an important role in the pathogenesis of the disease.
“Therefore, a strong inflammatory immune response is induced during aseptic meningitis and plays an important role in the pathogenesis of the disease.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAlthough patients with viral meningitis usually do not need to be hospitalized, treatment such as antipyretics, antiemetics, and analgesics can be taken at home; some patients, such as those who suffer from seizures, need to be under medical supervision.
“Although patients with viral meningitis usually do not need to be hospitalized, treatment should be provided, such as antipyretics, antiemetics, and analgesics, which can be taken at home. However, some patients, such as those who suffer from seizures, need to be under medical supervision [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Kumar R (2005) Aseptic meningitis: diagnosis and management. Indian J Pediatr 72(1):57–63 source
May combine two claims.
PremisecitationAn EV-D68 virus-like particle vaccine has been developed; it is composed of a recombinant baculovirus expressing 3CD protease and P1 precursor, and clinical trials showed high efficacy.
“Recently, an EV-D68 virus-like particle vaccine (VLP) has been developed [108]. The VLP is composed of a recombinant baculovirus expressing 3CD protease and P1 precursor. Clinical trials showed a high efficacy of the vaccine [108].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [108] Dai W et al (2018) A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice. Vaccine 36(5):653–659 source
May combine two claims.
PremisecitationAntiviral therapy in immunocompromised patients with HSV-induced meningitis should be started immediately, and any delay in administration can result in adverse complications.
“Regarding to HSV treatment, one study showed that antiviral therapy in immunocompromised patients with HSV-induced meningitis should be started immediately and that any delay in the administration of treatment can result in the development of adverse complications [102].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Momméja-Marin H et al (2003) Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis 37(11):1527–1533 source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
InterpretationreasoningThe lack of a receptor in the respiratory tract might explain why HPeV-3 commonly causes meningitis and neonatal sepsis, while HPeV-1 causes respiratory and gastrointestinal illness.
“In fact, the lack of a receptor in the respiratory tract might explain why HPeV-3 commonly causes meningitis and neonatal sepsis, while HPeV-1 causes respiratory and gastrointestinal illness.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSeveral arboviruses of different families have been associated with central nervous system infection and development of meningitis, including members of Flaviviridae (e.g., West Nile virus), Togaviridae (e.g., Eastern equine encephalitis virus), and Peribunyaviridae (e.g., La Crosse virus); most are zoonotic and transmitted to humans through arthropods such as mosquitoes, ticks, and sandflies.
“Several arboviruses of different families have been associated with CNS infection and development of meningitis. These include members of the families Flaviviridae (e.g., West Nile virus [WNV]), Togaviridae (e.g., Eastern equine encephalitis virus), and Peribunyaviridae (e.g., La Crosse virus). Most of these viruses are zoonotic and are transmitted to humans through arthropods such as mosquitoes,”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [94] Miller BR (2008) Arboviruses. In: Mahy BWJ, Van Regenmortel MHV (eds) Encyclopedia of virology (Third Edition). Academic Press, Oxford, pp 170–176 source
May combine two claims.
PremisecitationSeveral studies have shown that pleconaril shortens the course of symptoms, especially headache, but other studies have shown no significant difference between treatment and placebo groups.
“Several studies have shown that pleconaril plays an important role in shortening the course of symptoms, especially headache [6, 99]. However, other studies have shown that there was no significant difference between treatment and placebo groups [100].”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [6] Desmond R et al (2006) Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 50(7):2409–2414 source
- cites [99] Romero JR (2001) Pleconaril: a novel antipicornaviral drug. Expert Opin Investig Drugs 10(2):369–379 source
- cites [100] Abzug MJ et al (2003) Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr Infect Dis J 22(4):335–341 source
May combine two claims.
InterpretationreasoningCollectively, these findings can explain the spread of influenza virus to the central nervous system, where it has the potential to cause various neurological syndromes such as meningitis.
“Collectively, this can explain the spread of influenza virus to the CNS, where it has the potential to cause various neurological syndromes, such as meningitis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationHPeV can be transmitted from person to person through respiratory secretions and saliva, leading primarily to respiratory infections.
“HPeV can be transmitted from person to person through respiratory secretions and saliva, leading primarily to respiratory infections [77].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Romero JR, Modlin JF (2015) 175—human parechoviruses. In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's principles and practice of infectious diseases (Eighth Edition). Content Repository Only!: Philadelphia, pp 2091–2094.e2. source
May combine two claims.
PremisecitationPleconaril is licensed as intranasal therapy for the common cold, but it attains several-fold higher concentrations in the central nervous system, making it a potential treatment for brain-related diseases such as meningitis.
“It is licensed as intranasal therapy for the common cold, but it attains several-fold higher concentrations in the CNS, making it a potential treatment for brain-related diseases such as meningitis [99].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Romero JR (2001) Pleconaril: a novel antipicornaviral drug. Expert Opin Investig Drugs 10(2):369–379 source
May combine two claims.
PremisecitationThe use of acyclovir against HSV-2-induced meningitis was evaluated, with better outcomes observed in treated patients; however, one patient developed concentration difficulties as a meningitis symptom that lasted for approximately three months.
“The use of acyclovir against HSV-2-induced meningitis was also evaluated, with better outcomes observed in treated patients. However, one patient developed concentration difficulties as a meningitis symptom that lasted for approximately three months [103].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Bergström T, Alestig K (1990) Treatment of primary and recurrent herpes simplex virus type 2 induced meningitis with acyclovir. Scand J Infect Dis 22(2):239–240 source
May combine two claims.
PremisecitationNo specific treatment is prescribed for aseptic meningitis cases, and supportive medications are usually given to minimize disease complications such as fever and headache; full recovery takes from 5 to 14 days in the majority of cases.
“No specific treatment is prescribed for aseptic meningitis cases, and supportive medications are usually given to minimize disease complications such as fever and headache, and full recovery takes from 5 to 14 days in the majority of cases [5].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Kumar R (2005) Aseptic meningitis: diagnosis and management. Indian J Pediatr 72(1):57–63 source
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenViral meningitis often goes undetected or leads to a self-limited disease in adults, but severe complications can develop in infants and children, including high fever, mental retardation, and even death in some cases.
“It often goes undetected or leads to a self-limited disease in adults. However, severe complications can develop in infants and children, including high fever, mental retardation, and even death in some cases.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenViral meningitis is considered one of the most common clinical conditions affecting different age groups.
“Viral meningitis is considered one of the most common clinical conditions affecting different age groups.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenMolecular epidemiology studies of viral meningitis are scarce in many countries, including the MENA region.
“Molecular epidemiology studies of viral meningitis are scarce in many countries, including the MENA region.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenMany viral causative agents are associated with aseptic meningitis, such as enterovirus, parechovirus, and herpesviruses.
“Many viral causative agents are found to be associated with aseptic meningitis, such as enterovirus, parechovirus, and herpesviruses.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Findings from animal models and cell cultures used to describe viral meningitis pathogenesis are applicable to human disease.
“One study using a murine viral meningitis model in which mice were infected with lymphocytic choriomeningitis virus (LCMV) showed elevated levels of both IL-6 and INF-γ in CSF [50].”
“In addition, EV-D68 strains were able to infect and replicate in a human neuroblastoma cell line and a postnatal cortical neuron culture, but non-neurotropic strains were not [60].”
The paper relies on this without support.
Detection of viral nucleic acid in cerebrospinal fluid by PCR indicates that the detected virus is the cause of the meningitis.
“The gold standard tool for diagnosis of viral meningitis is the polymerase chain reaction (PCR), which detects and quantifies viral DNA or RNA in the patient’s CSF [41].”
“The most recently detected viral agent causing meningitis was reported in a case study of a 24-year-old male from Japan who had aseptic meningitis caused by SARS-CoV-2, which was demonstrated by performing an RT-PCR test on a CSF sample from the patient.”
The paper relies on this without support.
The cited epidemiological studies' case definitions and diagnostic methods are valid for estimating viral meningitis incidence and etiology.
“A study conducted in England between 2011 and 2014 showed that the incidence of viral meningitis was 2.73 per 100,000, with the largest number of cases caused by non-polio enteroviruses [8].”
Cites
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., Ueno, M., Sakata, H., Kondo, K., Myose, N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.062 · Cited by 2,024 · see citing works
Clinical Methods: The History, Physical, and Laboratory Examinations
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-7-563_2 · Cited by 1,406 · see citing works
Virus Infections in the Nervous System
Koyuncu, O. O., Hogue, I. B., & Enquist, L. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.03.010 · Cited by 594 · see citing works
Spear, P. G., & Longnecker, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10179-10185.2003 · Cited by 590 · see citing works
Etiology of aseptic meningitis and encephalitis in an adult population
Kupila, L., Vuorinen, T., Vainionpää, R., Hukkanen, V., Marttila, R. J., & Kotilainen, P. (2006) · Neurology · doi:10.1212/01.wnl.0000191407.81333.00 · Cited by 388 · see citing works
(1988) · Cited by 381 · see citing works
Activity of Pleconaril against Enteroviruses
Pevear, D. C., Tull, T. M., Seipel, M. E., & Groarke, J. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2109 · Cited by 368 · see citing works
Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis
Kim, J. V., Kang, S. S., Dustin, M. L., & McGavern, D. B. (2009) · Nature · doi:10.1038/nature07591 · Cited by 326 · see citing works
The role of receptor binding specificity in interspecies transmission of influenza viruses
Imai, M., & Kawaoka, Y. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.03.003 · Cited by 312 · see citing works
Whitley, R. J., & Lakeman, F. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.2.414 · Cited by 309 · see citing works
Wolthers, K. C., Benschop, K. S. M., Schinkel, J., Molenkamp, R., Bergevoet, R. M., Spijkerman, I. J. B., Kraakman, H. C., & Pajkrt, D. (2008) · Clinical Infectious Diseases · doi:10.1086/589752 · Cited by 252 · see citing works
Frei, K., Leist, T. P., Meager, A., Gallo, P., Leppert, D., Zinkernagel, R. M., & Fontana, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.1.449 · Cited by 245 · see citing works
Enterovirus D68 and acute flaccid myelitis—evaluating the evidence for causality
Messacar, K., Asturias, E. J., Hixon, A. M., Van Leer-Buter, C., Niesters, H. G. M., Tyler, K. L., Abzug, M. J., & Dominguez, S. R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30094-x · Cited by 234 · see citing works
Seehusen, D. A., Reeves, M. M., & Fomin, D. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-9979-6.00781-9 · Cited by 224 · see citing works
Enteroviruses as agents of emerging infectious diseases
Palacios, G., & Oberste, M. (2005) · Journal of Neurovirology · doi:10.1080/13550280591002531 · Cited by 223 · see citing works
Logan, S. A. E., & MacMahon, E. (2008) · BMJ · doi:10.1136/bmj.39409.673657.ae · Cited by 219 · see citing works
Enterovirus 71 infection and vaccines
Yi, E.-J., Shin, Y.-J., Kim, J.-H., Kim, T.-G., & Chang, S.-Y. (2017) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2017.6.1.4 · Cited by 203 · see citing works
McGill, F., Griffiths, M. J., Bonnett, L. J., Geretti, A. M., Michael, B. D., Beeching, N. J., McKee, D., Scarlett, P., Hart, I. J., Mutton, K. J., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30245-7 · Cited by 193 · see citing works
Enterovirus and parechovirus infection in children: a brief overview
de Crom, S. C. M., Rossen, J. W. A., van Furth, A. M., & Obihara, C. C. (2016) · European Journal of Pediatrics · doi:10.1007/s00431-016-2725-7 · Cited by 192 · see citing works
Rotbart, H. A. (2000) · Seminars in Neurology · doi:10.1055/s-2000-9427 · Cited by 182 · see citing works
Review: Pathophysiology and treatment of bacterial meningitis
Hoffman, O., & Weber, J. R. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609337975 · Cited by 179 · see citing works
Verstrepen, W. A., Kuhn, S., Kockx, M. M., Van De Vyvere, M. E., & Mertens, A. H. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.11.4093-4096.2001 · Cited by 177 · see citing works
Wong, K. T., Munisamy, B., Ong, K. C., Kojima, H., Noriyo, N., Chua, K. B., Ong, B. B., & Nagashima, K. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318163a990 · Cited by 159 · see citing works
Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy
Desmond, R. A., Accortt, N. A., Talley, L., Villano, S. A., Soong, S.-J., & Whitley, R. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-06 · Cited by 154 · see citing works
Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis
Bergstrom, T., Vahlne, A., lestig, K., Jeansson, S., Forsgren, M., & Lycke, E. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.2.322 · Cited by 141 · see citing works
Aseptic Meningitis and Viral Myelitis
Irani, D. N. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.03.003 · Cited by 139 · see citing works
Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route
Munster, V. J., Prescott, J. B., Bushmaker, T., Long, D., Rosenke, R., Thomas, T., Scott, D., Fischer, E. R., Feldmann, H., & de Wit, E. (2012) · Scientific Reports · doi:10.1038/srep00736 · Cited by 139 · see citing works
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
ABZUG, M. J., CLOUD, G., BRADLEY, J., SÁNCHEZ, P. J., ROMERO, J., POWELL, D., LEPOW, M., MANI, C., CAPPARELLI, E. V., BLOUNT, S., et al. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000059765.92623.70 · Cited by 138 · see citing works
Aseptic meningitis in adults and children: diagnostic and management challenges
Shukla, B., Aguilera, E. A., Salazar, L., Wootton, S. H., Kaewpoowat, Q., & Hasbun, R. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.07.016 · Cited by 135 · see citing works
West Nile Virus: Immunity and Pathogenesis
Lim, S. M., Koraka, P., Osterhaus, A. D. M. E., & Martina, B. E. E. (2011) · Viruses · doi:10.3390/v3060811 · Cited by 133 · see citing works
Pleconaril: a novel antipicornaviral drug
Romero, J. R. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.2.369 · Cited by 131 · see citing works
ICAM-5/Telencephalin Is a Functional Entry Receptor for Enterovirus D68
Wei, W., Guo, H., Chang, J., Yu, Y., Liu, G., Zhang, N., Willard, S. H., Zheng, S., & Yu, X.-F. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.09.013 · Cited by 131 · see citing works
Neurotropic Enterovirus Infections in the Central Nervous System
Huang, H.-I., & Shih, S.-R. (2015) · Viruses · doi:10.3390/v7112920 · Cited by 130 · see citing works
Keratinocytes Are Cell Targets of West Nile Virus <i>In Vivo</i>
Lim, P.-Y., Behr, M. J., Chadwick, C. M., Shi, P.-Y., & Bernard, K. A. (2011) · Journal of Virology · doi:10.1128/jvi.02692-10 · Cited by 121 · see citing works
Methods for Rapid Diagnosis of Meningitis Etiology in Adults
Poplin, V., Boulware, D. R., & Bahr, N. C. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0333 · Cited by 119 · see citing works
Kupila, L., Vuorinen, T., Vainionpaa, R., Marttila, R. J., & Kotilainen, P. (2005) · Clinical Infectious Diseases · doi:10.1086/428581 · Cited by 112 · see citing works
Enteroviruses: A Gut-Wrenching Game of Entry, Detection, and Evasion
Wells, A. I., & Coyne, C. B. (2019) · Viruses · doi:10.3390/v11050460 · Cited by 109 · see citing works
Infections of the nervous system
Parikh, V., Tucci, V., & Galwankar, S. (2012) · International Journal of Critical Illness and Injury Science · doi:10.4103/2229-5151.97273 · Cited by 106 · see citing works
Brown, D. M., Hixon, A. M., Oldfield, L. M., Zhang, Y., Novotny, M., Wang, W., Das, S. R., Shabman, R. S., Tyler, K. L., & Scheuermann, R. H. (2018) · mBio · doi:10.1128/mbio.01954-18 · Cited by 105 · see citing works
Aseptic meningitis: Diagnosis and management
Kumar, R. (2005) · The Indian Journal of Pediatrics · doi:10.1007/bf02760582 · Cited by 93 · see citing works
Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis
Opavsky, M. A., Martino, T., Rabinovitch, M., Penninger, J., Richardson, C., Petric, M., Trinidad, C., Butcher, L., Chan, J., & Liu, P. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213971 · Cited by 91 · see citing works
Ortner, B., Huang, C., Schmid, D., Mutz, I., Wewalka, G., Allerberger, F., Yang, J., & Huemer, H. P. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21374 · Cited by 91 · see citing works
Management of Viral Central Nervous System Infections: A Primer for Clinicians
Bookstaver, P. B., Mohorn, P. L., Shah, A., Tesh, L. D., Quidley, A. M., Kothari, R., Bland, C. M., & Weissman, S. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517703342 · Cited by 91 · see citing works
Kadambari, S., Braccio, S., Ribeiro, S., Allen, D. J., Pebody, R., Brown, D., Cunney, R., Sharland, M., & Ladhani, S. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-315643 · Cited by 88 · see citing works
Aurelius, E., Franzen-Rohl, E., Glimaker, M., Akre, O., Grillner, L., Jorup-Ronstrom, C., Studahl, M., & the HSV-2 Meningitis Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis031 · Cited by 86 · see citing works
Tabor-Godwin, J. M., Ruller, C. M., Bagalso, N., An, N., Pagarigan, R. R., Harkins, S., Gilbert, P. E., Kiosses, W. B., Gude, N. A., Cornell, C. T., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1860-10.2010 · Cited by 84 · see citing works
Accuracy of physical signs for detecting meningitis: A hospital-based diagnostic accuracy study
Waghdhare, S., Kalantri, A., Joshi, R., & Kalantri, S. (2010) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2010.06.003 · Cited by 82 · see citing works
Current Understanding of Human Enterovirus D68
Sun, J., Hu, X.-Y., & Yu, X.-F. (2019) · Viruses · doi:10.3390/v11060490 · Cited by 81 · see citing works
Visintin, C., Mugglestone, M. A., Fields, E. J., Jacklin, P., Murphy, M. S., Pollard, A. J., & on behalf of the Guideline Development Group (2010) · BMJ · doi:10.1136/bmj.c3209 · Cited by 79 · see citing works
Herpes Simplex Virus Type 2 as a Cause of Severe Meningitis in Immunocompromised Adults
Mommeja-Marin, H., Lafaurie, M., Scieux, C., Galicier, L., Oksenhendler, E., & Molina, J.-M. (2003) · Clinical Infectious Diseases · doi:10.1086/379520 · Cited by 76 · see citing works
Wolinsky, J. S., Klassen, T., & Baringer, J. R. (1976) · Journal of Infectious Diseases · doi:10.1093/infdis/133.3.260 · Cited by 75 · see citing works
Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008
Kim, H.-J., Kang, B., Hwang, S., Hong, J., Kim, K., & Cheon, D.-S. (2012) · Virology Journal · doi:10.1186/1743-422x-9-38 · Cited by 70 · see citing works
Frantzidou, F., Kamaria, F., Dumaidi, K., Skoura, L., Antoniadis, A., & Papa, A. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02233.x · Cited by 65 · see citing works
Esposito, S., Bosis, S., Niesters, H., & Principi, N. (2015) · Viruses · doi:10.3390/v7112925 · Cited by 65 · see citing works
de Crom, S. C. M., Obihara, C. C., de Moor, R. A., Veldkamp, E. J. M., van Furth, A. M., & Rossen, J. W. A. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.07.017 · Cited by 61 · see citing works
Epidemiology and clinical outcomes of viral central nervous system infections
Ben Abid, F., Abukhattab, M., Ghazouani, H., Khalil, O., Gohar, A., Al Soub, H., Al Maslamani, M., Al Khal, A., Al Masalamani, E., Al Dhahry, S., et al. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.06.008 · Cited by 59 · see citing works
Seiden, J. A., Zorc, J. J., Hodinka, R. L., & Shah, S. S. (2010) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3181ce2fad · Cited by 58 · see citing works
Paintsil, E., & Cheng, Y.-C. (2009) · Encyclopedia of Microbiology · doi:10.1016/b978-012373944-5.00178-4 · Cited by 55 · see citing works
Jaijakul, S., Salazar, L., Wootton, S. H., Aguilera, E., & Hasbun, R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.04.010 · Cited by 53 · see citing works
Treatment of Primary and Recurrent Herpes Simplex Virus Type 2 Induced Meningitis with Acyclovir
Bergström, T., & Alestig, K. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009037909 · Cited by 52 · see citing works
Ramilo, O. (1990) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1990.02150270099034 · Cited by 51 · see citing works
Clinical Analysis of 134 Children with Nervous System Damage Caused by Enterovirus 71 Infection
Hu, Y., Jiang, L., & Peng, H.-L. (2015) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000711 · Cited by 50 · see citing works
Yamada, M., Bingham, J., Payne, J., Rookes, J., Lowther, S., Haining, J., Robinson, R., Johnson, D., & Middleton, D. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1010-8 · Cited by 50 · see citing works
Molecular Pathogenicity of Enteroviruses Causing Neurological Disease
Majer, A., McGreevy, A., & Booth, T. F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00540 · Cited by 50 · see citing works
A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice
Dai, W., Zhang, C., Zhang, X., Xiong, P., Liu, Q., Gong, S., Geng, L., Zhou, D., & Huang, Z. (2018) · Vaccine · doi:10.1016/j.vaccine.2017.12.057 · Cited by 46 · see citing works
Characteristics of pediatric patients with enterovirus meningitis and no cerebral fluid pleocytosis
de Crom, S. C. M., van Furth, M. A. M., Peeters, M. F., Rossen, J. W. A., & Obihara, C. C. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-011-1626-z · Cited by 45 · see citing works
Echoviruses are a major cause of aseptic meningitis in infants and young children in Kuwait
Dalwai, A., Ahmad, S., & Al-Nakib, W. (2010) · Virology Journal · doi:10.1186/1743-422x-7-236 · Cited by 45 · see citing works
Etiology of aseptic meningitis and clinical characteristics in immune‐competent adults
Han, S., Choi, H., Kim, J., Park, K., Youn, Y. C., & Shin, H. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24316 · Cited by 45 · see citing works
Meningitis in children in Fiji: etiology, epidemiology, and neurological sequelae
Biaukula, V., Tikoduadua, L., Azzopardi, K. I., Seduadua, A., Temple, B., Richmond, P., Robins-Browne, R. M., Mulholland, E. K., & Russell, F. M. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.12.013 · Cited by 44 · see citing works
Abdelkader, M. M., Aboshanab, K. M., El-Ashry, M. A., & Aboulwafa, M. M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0171349 · Cited by 44 · see citing works
The Epidemiology of Viral Meningitis Hospitalization in Childhood
Hviid, A., & Melbye, M. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181567d31 · Cited by 44 · see citing works
Epidemiology of meningitis in Al-Ain, United Arab Emirates, 2000–2005
Dash, N., Ameen, A. S., Sheek-Hussein, M. M., & Smego, R. A. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.05.009 · Cited by 42 · see citing works
Trends in the Management of Viral Meningitis at United States Children’s Hospitals
Nigrovic, L. E., Fine, A. M., Monuteaux, M. C., Shah, S. S., & Neuman, M. I. (2013) · PEDIATRICS · doi:10.1542/peds.2012-3077 · Cited by 41 · see citing works
Hassan, S. T. S., Šudomová, M., Berchová-Bímová, K., Šmejkal, K., & Echeverría, J. (2019) · Molecules · doi:10.3390/molecules24162912 · Cited by 41 · see citing works
Siegers, J. Y., van de Bildt, M. W. G., Lin, Z., Leijten, L. M., Lavrijssen, R. A. M., Bestebroer, T., Spronken, M. I. J., De Zeeuw, C. I., Gao, Z., Schrauwen, E. J. A., et al. (2019) · Journal of Virology · doi:10.1128/jvi.02273-18 · Cited by 40 · see citing works
Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018
González-Sanz, R., Taravillo, I., Reina, J., Navascués, A., Moreno-Docón, A., Aranzamendi, M., Romero, M. P., del Cuerpo, M., Pérez-González, C., Pérez-Castro, S., et al. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1668243 · Cited by 39 · see citing works
Hudson, J. A., Broad, J., Martin, N. G., Sadarangani, M., Galal, U., Kelly, D. F., Pollard, A. J., & Kadambari, S. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2083 · Cited by 38 · see citing works
Akuzawa, N., Harada, N., Hatori, T., Imai, K., Kitahara, Y., Sakurai, S., & Kurabayashi, M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-3 · Cited by 37 · see citing works
Persistent Coxsackie B encephalitis: Report of a case and review of the literature
Berger, J. R., Chumley, W., Pittman, T., Given, C., & Nuovo, G. (2006) · Journal of Neurovirology · doi:10.1080/13550280601090546 · Cited by 32 · see citing works
Buch, K., Bodilsen, J., Knudsen, A., Larsen, L., Helweg-Larsen, J., Storgaard, M., Brandt, C., Wiese, L., Østergaard, C., Nielsen, H., et al. (2018) · Infectious Diseases · doi:10.1080/23744235.2018.1441539 · Cited by 32 · see citing works
Neurologic complications of 2009 influenza A (H1N1): Heightened attention on an ongoing question
Sejvar, J. J., & Uyeki, T. M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6b869 · Cited by 27 · see citing works
Structural Basis of Nonenveloped Virus Cell Entry
Stewart, P. L., Dermody, T. S., & Nemerow, G. R. (2003) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(03)01013-1 · Cited by 26 · see citing works
Polarized Entry of Human Parechoviruses in the Airway Epithelium
Karelehto, E., Cristella, C., Yu, X., Sridhar, A., Hulsdouw, R., de Haan, K., van Eijk, H., Koekkoek, S., Pajkrt, D., de Jong, M. D., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00294 · Cited by 26 · see citing works
Enteroviral meningitis in Northern Jordan: Prevalence and association with clinical findings
Meqdam, M. M., Khalousi, M. M., & Al‐Shurman, A. (2001) · Journal of Medical Virology · doi:10.1002/jmv.2133 · Cited by 26 · see citing works
Detection of enteroviruses in pediatric patients with aseptic meningitis
Shaker, O. G., & Abdelhamid, N. (2015) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2014.12.004 · Cited by 26 · see citing works
Enterovirus 71 infects brain-derived neural progenitor cells
Huang, H.-I., Lin, J.-Y., Chen, H.-H., Yeh, S.-B., Kuo, R.-L., Weng, K.-F., & Shih, S.-R. (2014) · Virology · doi:10.1016/j.virol.2014.09.017 · Cited by 25 · see citing works
Dumaidi, K., & Al-Jawabreh, A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172357 · Cited by 25 · see citing works
Akkoc, G., Kadayifci, E. K., Karaaslan, A., Atici, S., Yakut, N., Ocal Demir, S., Soysal, A., & Bakir, M. (2016) · Case Reports in Infectious Diseases · doi:10.1155/2016/7549252 · Cited by 25 · see citing works
Smuts, H., Cronje, S., Thomas, J., Brink, D., Korsman, S., & Hardie, D. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3641-4 · Cited by 25 · see citing works
Puccini, J. M., Ruller, C. M., Robinson, S. M., Knopp, K. A., Buchmeier, M. J., Doran, K. S., & Feuer, R. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2013.138 · Cited by 24 · see citing works
Skin rash in meningitis and meningoencephalitis
Tsai, J., Nagel, M. A., & Gilden, D. (2013) · Neurology · doi:10.1212/wnl.0b013e3182918cda · Cited by 22 · see citing works
Adherence to international guidelines for the treatment of meningitis infections in Lebanon
Haydar, S. M., Hallit, S. R., Hallit, R. R., Salameh, P. R., Faddoul, L. J., Chahine, B. A., & Malaeb, D. N. (2019) · Saudi Medical Journal · doi:10.15537/smj.2019.3.23965 · Cited by 21 · see citing works
Comparative analyses of influenza virus receptor distribution in the human and mouse brains
Kim, M., Yu, J. E., Lee, J.-H., Chang, B.-J., Song, C.-S., Lee, B., Paik, D. J., & Nahm, S.-S. (2013) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2013.05.002 · Cited by 20 · see citing works
Iguchi, M., Noguchi, Y., Yamamoto, S., Tanaka, Y., & Tsujimoto, H. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012824.pub2 · Cited by 20 · see citing works
Clinical picture of meningitis in the adult patient and its relationship with age
Magazzini, S., Nazerian, P., Vanni, S., Paladini, B., Pepe, G., Casanova, B., Crugnola, C., & Grifoni, S. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0765-1 · Cited by 19 · see citing works
Méreaux, J., Picone, O., Vauloup-Fellous, C., Khediri, Z., Benachi, A., Mandelbrot, L., & Ayoubi, J.-M. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2017.02.004 · Cited by 18 · see citing works
Iguchi, M., Noguchi, Y., Yamamoto, S., Tanaka, Y., & Tsujimoto, H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012824 · Cited by 17 · see citing works
Appraisal of Kernig`s and Brudzinski′s sign in meningitis
Mehndiratta, M., Nayak, R., Garg, H., Kumar, M., & Pandey, S. (2012) · Annals of Indian Academy of Neurology · doi:10.4103/0972-2327.104337 · Cited by 17 · see citing works
Microbial study of meningitis and encephalitis cases.
(2007) · Cited by 16 · see citing works
Liang, C.-Y., Yang, C.-H., & Lin, J.-N. (2018) · Medical Principles and Practice · doi:10.1159/000487398 · Cited by 14 · see citing works
H7N9 Influenza A-induced Pneumonia Associated with Acute Myelitis in an Adult
Xia, J.-B., Zhu, J., Hu, J., Wang, L.-M., & Zhang, H. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1801 · Cited by 14 · see citing works
Echovirus 30 Induced Neuronal Cell Death through TRIO-RhoA Signaling Activation
Lee, J.-W., Yeo, S.-G., Kang, B.-H., Lee, H.-K., Kim, J.-W., Lee, S.-H., Kim, K.-S., & Cheon, D.-S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036656 · Cited by 12 · see citing works
Kato, K., Hara, S., Kawada, J.-I., & Ito, Y. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.08.005 · Cited by 12 · see citing works
A history of viral infections of the central nervous system
Booss, J., & Tselis, A. C. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53488-0.00001-8 · Cited by 12 · see citing works
Paediatric enterovirus meningitis without cerebrospinal fluid pleocytosis
Alhazmi, A., Lazrek, M., Alidjinou, E. K., Descombes, G., Engelmann, I., & Hober, D. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.11.006 · Cited by 9 · see citing works
Caractéristiques clinicobiologiques des méningites à Enterovirus de l’adulte : étude de 59 cas
Méchaï, F., Rivière, F., Roux, X., Mérens, A., Bigaillona, C., Ficko, C., Imbert, P., & Rapp, C. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.04.003 · Cited by 9 · see citing works
Miller, B. R. (2008) · Encyclopedia of Virology · doi:10.1016/b978-012374410-4.00619-1 · Cited by 9 · see citing works
Ghuneim, N. (2016) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.1000132 · Cited by 8 · see citing works
Romero, J. R., & Modlin, J. F. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00175-2 · Cited by 8 · see citing works
Characterization of Infections of Human Leukocytes by Non-Polio Enteroviruses
Hwang, J. Y., Jun, E. J., Seo, I., Won, M., Ahn, J., Kim, Y. K., & Lee, H. (2012) · Intervirology · doi:10.1159/000329987 · Cited by 7 · see citing works
Revision of Meningitis Surveillance System in Jordan during 2001 and 2014 Years
alzein, K. J. (2016) · Epidemiology Open Access · doi:10.4172/2161-1165.1000220 · Cited by 7 · see citing works
Burrell, C. J., Howard, C. R., & Murphy, F. A. (2017) · Fenner and White's Medical Virology · doi:10.1016/b978-0-12-375156-0.00032-1 · Cited by 7 · see citing works
Immunopathology in the brain of mice following vertical transmission of Coxsackievirus B4
Jmii, H., Halouani, A., Abdeli, M., Aouni, M., Fisson, S., & Jaïdane, H. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.103965 · Cited by 6 · cited 2× · see citing works
“Moreover, analysis of brain tissues obtained from mice born to mothers inoculated with coxsackievirus B4 showed signs of meningitis and accumulation of immune cells (mainly T cells) and increased secretion of inflammatory cytokines and chemokines (IL6, TNF-α, IFNα and MCP-1) [68].”
Background(2012) · doi:10.1016/b978-0-7020-4089-4.00063-9 · Cited by 5 · see citing works
Repeated viral meningitis in a newborn
Alhazmi, A., Lazrek, M., Alidjinou, E. K., Engelmann, I., Schuffenecker, I., Dubos, F., & Hober, D. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00829-0 · Cited by 5 · see citing works
(2014) · UvA-DARE (University of Amsterdam) · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 117 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Hersi K, Gonzalez FJ, Kondamudi NP. Meningitis. [Updated 2020 Nov 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459360
- Logan SAE, MacMahon E (2008b) Viral meningitis. BMJ (Clinical research ed.) 336(7634):36–40 · DOI · Paper page
Cited by
Sorted by citations
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ribeiro, A. I., Dias, A., & Zille, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03891 · Cited by 281 · see citing works
Pathogens infecting the central nervous system
Govic, Y. L., Demey, B., Cassereau, J., Bahn, Y., & Papon, N. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010234 · Cited by 78 · see citing works
Al-Mekhlafi, A., Sühs, K., Schuchardt, S., Kuhn, M., Müller‐Vahl, K., Trebst, C., Skripuletz, T., Klawonn, F., Stangel, M., & Peßler, F. (2021) · Cells · doi:10.3390/cells10051115 · Cited by 25 · see citing works
Bacterial meningitis in the early postnatal mouse studied at single-cell resolution
Wang, J., Rattner, A., & Nathans, J. (2023) · eLife · doi:10.7554/elife.86130 · Cited by 25 · see citing works
Association between temperature variability and global meningitis incidence
Chen, J., Jiao, Z., Liang, Z., Ma, J., Xu, M. Q., Biswal, S. S., Ramanathan, M., Sun, S., & Zhang, Z. (2022) · Environment International · doi:10.1016/j.envint.2022.107649 · Cited by 26 · see citing works
Al‐Qahtani, S. M., Shati, A. A., Alqahtani, Y. A., & Ali, A. S. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.923125 · Cited by 30 · see citing works
Guo, L. J., Chen, H., Fu, S., Liu, J., Zhang, Y., Qiu, Y., & Chen, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840399 · Cited by 17 · see citing works
Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel
Humisto, A., Antikainen, J., Holma, T., Jarva, H., Toivonen, A., Loginov, R., & Mannonen, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.05144-22 · Cited by 21 · see citing works
Rohani, H., Arjmand, R., Mozhgani, S., Shafiee, A., Amini, M. J., & Forghani-Ramandi, M.-M. (2023) · Turkish Archives of Pediatrics · doi:10.5152/turkarchpediatr.2023.23007 · Cited by 20 · see citing works
Metabolic response to CNS infection with flaviviruses
Dobrzyńska, M., Moniuszko-Malinowska, A. M., & Skrzydlewska, E. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02898-4 · Cited by 17 · see citing works
Sun, M., Manson, M. L., Guo, T., & de Lange, E. C. M. (2024) · CNS Drugs · doi:10.1007/s40263-024-01082-3 · Cited by 17 · see citing works
Structural basis for neutralization of enterovirus
(2021) · doi:10.1016/j.coviro.2021.10.006 · Cited by 15 · see citing works
Meningitis in Children: Still a Can’t-Miss Diagnosis
Skar, G. L., Flannigan, L., Latch, R. L., & Snowden, J. A. (2024) · Pediatrics in Review · doi:10.1542/pir.2023-006013 · Cited by 23 · see citing works
Leuci, S., Coppola, N., Cantile, T., Calabria, E., Mihai, L. L., & Mignogna, M. D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19073919 · Cited by 12 · see citing works
Understanding neurotropic enteric viruses: routes of infection and mechanisms of attenuation
Lulla, V., & Sridhar, A. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05450-6 · Cited by 13 · see citing works
Tang, C., Han, R., Yang, J., Wu, N., & He, D. (2025) · Infection · doi:10.1007/s15010-025-02483-2 · Cited by 14 · see citing works
Nanoparticle-based Gene Therapy for Neurodegenerative Disorders
Ereej, N., Hameed, H., Khan, M. A., Faheem, S., & Hameed, A. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575301011240407082559 · Cited by 13 · see citing works
Zhang, Y., Xu, L., Zhang, Z., Su, X., Wang, Z., & Wang, T. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.08.007 · Cited by 12 · see citing works
Carmona, R., Cilli, A., da Costa, A. C., Reis, F. C., Leal, E. D. S., dos Santos, F. C. P., Machado, B. C., Lopes, C. S., Afonso, A. M. S., & Timenetsky, M. D. C. S. T. (2023) · Microorganisms · doi:10.3390/microorganisms12010019 · Cited by 12 · see citing works
Plant based food bioactives: A boon or bane for neurological disorders
Choudhary, N., Tewari, D., Nabavi, S. F., Kashani, H. R. K., Lorigooini, Z., Filosa, R., Badrealam, K. F., Masoudian, N., & Nabavi, S. M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2131729 · Cited by 11 · see citing works
Characteristics of HHV-7 meningitis: a systematic review
Yarmohammadi, H., Razavi, A., Farahani, M. S., Soltanipur, M., & Amini, M. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11950-5 · Cited by 10 · see citing works
Pediatric Headache Attributed to Infection
(2021) · doi:10.1016/j.spen.2021.100923 · Cited by 9 · see citing works
Lu, Y., Zhang, Y., Lou, Z., He, X., Zhang, Q., Zhang, Q., Shu, Z., Chen, H., Zhu, H., Song, Z., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02264-23 · Cited by 9 · see citing works
Reversing neural circuit and behavior deficit in mice exposed to maternal inflammation by Zika virus
Ma, L., Wang, J., Ge, J., Wang, Y., Zhang, W., Du, Y., Luo, J., Li, Y., Wang, F., Fan, G., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051978 · Cited by 9 · see citing works
Kozioł, A., Pupek, M., & Lewandowski, Ł. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115685 · Cited by 8 · see citing works
Viral Meningitis and Encephalitis Update
Garber, B., & Glauser, J. (2024) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-024-00294-7 · Cited by 13 · see citing works
Nanotherapeutics for Meningitis: Enhancing Drug Delivery Across the Blood-Brain Barrier
Sharma, H., Narayanan, K. B., Ghosh, S., Singh, D. K. K., Rehan, P., Amist, A. D., Bhaskar, R., & Sinha, J. K. (2025) · Biomimetics · doi:10.3390/biomimetics10010025 · Cited by 9 · see citing works
Roxas, P. B., Cruz, J., Horelka, N. R., Burgos, C., Radwanski, J., Baires, F., Sierra‐Hoffman, M., Hesse, H., & Madril, A. C. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123281 · Cited by 7 · see citing works
Sirota, S. B., Bender, R. G., Dominguez, R.-M. V., Vongpradith, A., Movo, A., Swetschinski, L. R., Araki, D. T., Han, C., Wool, E. E., Jabbar, A. A. J., et al. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(26)00101-8 · Cited by 7 · see citing works
Progress in etiological diagnosis of viral meningitis
Xu, H., Chen, P., Guo, S., Shen, X., & Lu, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1193834 · Cited by 11 · see citing works
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
Zhao, J., Lin, B.-L., Luo, C. H., Yi, Y.-L., Huang, P., Chen, Y., Zhao, S., Huang, Z.-J., Ma, X., & Huang, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05794-4 · Cited by 7 · see citing works
Neurological Emergencies in the Intensive Care Unit
(2022) · doi:10.1097/cnq.0000000000000435 · Cited by 6 · see citing works
Foreign Contaminants Target Brain Health
Agarwal, U., Pannu, A. S., & Tonk, R. K. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273338071241213101016 · Cited by 6 · see citing works
Li, X., Sun, S., & Zhang, H. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-01820-y · Cited by 6 · see citing works
Graham, E. E., Tetens, M. M., Bodilsen, J., Andersen, N. S., Dessau, R. B., Ellermann‐Eriksen, S., Franck, K. T., Midgley, S., Møller, J. K., Nielsen, A. C. Y., et al. (2024) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piae125 · Cited by 5 · see citing works
Jiang, C., Xu, Z., Li, J., Zhang, J., Xue, X., Jiang, J., Jiang, G., Wang, X., Peng, Y. F., Chen, T., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1094347 · Cited by 6 · see citing works
Faller, C. J., Kursancew, A. C. S., Brandão, B., Duarte, N. G., Noetzold, J. T., Studnicka, N., Mathias, K., Petronilho, F. C., STRECK, E. L., & Generoso, J. S. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01658-y · Cited by 4 · see citing works
The meninges as a neuroimmune interface: structure, barriers and roles in CNS disease
Joost, S., Kaddatz, H., Vankriekelsvenne, E., & Brandenburg, L. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-026-00795-5 · Cited by 7 · see citing works
Epidemiology and aetiology of the 2023 meningitis outbreak among children in Iraq
Najmadden, Z. B., Sidiq, K. R., Sabir, D. K., et al. (2024) · Eastern Mediterranean Health Journal · doi:10.26719/2024.30.5.350 · Cited by 4 · see citing works
Jiang, H., Yu, X., Fan, J., Song, H., & Yang, Y. (2025) · AMB Express · doi:10.1186/s13568-025-01893-7 · Cited by 4 · see citing works
Bacterial and Viral Infectious Disease of the Spine
(2024) · doi:10.1016/j.mric.2023.12.003 · Cited by 4 · see citing works
Vollmuth, Y., Soric, B., Beer, J., Behrends, U., Paolini, M., Blaschek, A., Meyer-Bühn, M., Klein, C., Hübner, J., Dobler, G., et al. (2026) · Infection · doi:10.1007/s15010-026-02811-0 · Cited by 3 · see citing works
Silva, L. H. V., Giurisatto, M. J. M., Marins, T. M., Filho, J. E. B. A., Alvarenga, M. D. S., & de Menezes, V. M. (2023) · Revista Eletrônica Acervo Médico · doi:10.25248/reamed.e12414.2023 · Cited by 3 · see citing works
García-Sánchez, C., Bloise, I., García‐Rodríguez, J., & Cendejas‐Bueno, E. (2023) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2023.116031 · Cited by 3 · see citing works
Hathcock, S. F., Mamana, J., Keyzer, T. E., Vollmuth, N., Shokri, M.-R., Mauser, H. D., Correll, R. N., Lam, D. W., Kim, B. J., & Sin, J. (2024) · Journal of Virology · doi:10.1128/jvi.01824-24 · Cited by 3 · see citing works
Song, P., Seok, J. M., Kim, S., Choi, J.-H., Bae, J. Y., Yu, S. N., Park, J., Choi, K., Yang, Y., Jeong, D., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14090998 · Cited by 4 · see citing works
Wu, L., Shi, W., Peng, W., & Li, G. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113985 · Cited by 3 · see citing works
Viral infection and sudden non-cardiac death: A systematic review
Cordeiro, F. P., & Cainé, L. (2024) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2024.102727 · Cited by 3 · see citing works
Enteroviral meningitis in children: Clinical and laboratory features with and without pleocytosis
Şen, Z. S., Özdem, S., Yalçınkaya, R., Cinni, R. G., Polat, E., Polat, M., Kaman, A., Teke, T. A., Tanır, G., & Öz, F. N. (2024) · Klinische Pädiatrie · doi:10.1055/a-2345-3186 · Cited by 2 · see citing works
Imishti, A., Nissen, M. J., Øvrehus, A. L. H., & Larsen, L. (2025) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2025.2463960 · Cited by 2 · see citing works
Cohen, R., Mahajnah, M. M., Shlonsky, Y., Golan-Shany, O., Romem, A., Halevy, A., Natan, K., & Genizi, J. (2023) · Brain Sciences · doi:10.3390/brainsci13020361 · Cited by 2 · see citing works
Factors Associated with In-Hospital Mortality in Adult Patients with Bacterial Meningitis
Makowiecki, M., Paciorek, M., Bednarska, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247845 · Cited by 2 · see citing works
Faroby, M. H. Z. A., Fadhilah, H. N., Amiroch, S., & Hidayat, R. S. (2022) · Kinetik Game Technology Information System Computer Network Computing Electronics and Control · doi:10.22219/kinetik.v7i2.1424 · Cited by 2 · see citing works
From cellular heterogeneity to precision medicine: single-cell multi-omics in CNS disease research
Liu, T., Zhang, Y., Hou, W., Hao, H., Geng, A., Zhao, G., & Zhang, Y. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1848558 · Cited by 2 · see citing works
Wu, C., Sun, X., Zhang, W., Yang, Y., Niu, P., Chen, J., Zhang, X., Lu, R., Wang, W., Chen, Z., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-12204-7 · Cited by 2 · see citing works
Molecular and Cellular Mechanism of Pathogen Invasion into the Central Nervous System: Meningitis
Singh, P., Gupta, K. C., Sharma, M., & Kumar, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_14 · Cited by 2 · see citing works
Non-coding RNAs in meningitis: Key regulators of immune response and inflammation
Imran, M., Abida, A., Kamal, M., Fares, M. A. A., Hazazi, A., Sabour, A. A. A., Alshiekheid, M. A., Sulaiman, T., Abdulkhaliq, A. A., Kaabi, N. A. M. A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155626 · Cited by 2 · see citing works
Wollenweber, M., Beyrer, K., Baillot, A., Monazahian, M., Mertens, E. I., & Rettenbacher-Riefler, S. (2026) · Eurosurveillance · doi:10.2807/1560-7917.es.2026.31.6.2500625 · Cited by 1 · see citing works
Xiong, W., Yin, H., Gao, L. S., & Liang, S. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s537261 · Cited by 1 · see citing works
Pan, Y., Nie, Z., Jiang, H., & Yang, Y. (2026) · Discover Immunity. · doi:10.1007/s44368-025-00017-4 · Cited by 1 · see citing works
Infections of the Central Nervous System
Dobosz, M., Arciszewska, K., Bogoń, A., et al. (2024) · Quality in Sport · doi:10.12775/qs.2024.20.53865 · Cited by 1 · see citing works
Brunetta, A. M. A., Porazzi, G. M., Vinagre, J. M. D. Q., Maitelli, L. D. P., Hoffmann‐Santos, H. D., Elias, R. M., & Dombroski, T. C. D. (2022) · COORTE - Revista Científica do Hospital Santa Rosa · doi:10.52908/coorte.v0i14.254 · Cited by 1 · see citing works
Enhanced pathogen identification among patients with clinically suspected meningitis
Moleleki, M., Nel, P., Matukane, S. R., Cloete, S., Abrahams, Z., Wolter, N., & Whitelaw, A. C. (2024) · Southern African Journal of Infectious Diseases · doi:10.4102/sajid.v39i1.688 · Cited by 1 · see citing works
Shakoury, A. A. (2019) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2019.15.002680 · Cited by 1 · see citing works
Saha, T., Moonla, C., Nandhakumar, P., Ji, G., Fishman, H., Jiang, X., Ding, S., Sabbagh, B., & Wang, J. (2026) · Matter · doi:10.1016/j.matt.2026.102967 · Cited by 1 · see citing works
Buriko, Y., & Tinsley, A. (2025) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2025.01.007 · Cited by 1 · see citing works
Sensitivity and Specificity of Jolt Accentuation Maneuver in Diagnosis of Acute Meningitis
Khan, M. J., Nawaz, K. H., Saleem, M. I., Jadoon, S. B., Khan, S., Shah, P. M., Ahmed, M., & Habib, M. F. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i3.1280 · Cited by 1 · see citing works
Molecular detection and serotyping of acute bacterial meningitis pathogens in Indian children
Nagaraj, G., Govindan, V., Kumar, C. P. G., Awasthi, S., Das, B. K., Gautam, H., Biswas, D., Ezhilarasi, S., Subburaju, N., Bavdekar, A., et al. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05198-2 · Cited by 2 · see citing works
Lee, Y. J., Yang, E. H., Jo, Y. H., Choi, S. H., Yoo, H. W., Cho, H. Y., Kwak, M. J., Park, S. J., Park, K. H., & Kim, Y. M. (2023) · Annals of Child Neurology · doi:10.26815/acn.2022.00388 · Cited by 1 · see citing works
Acute Viral Meningitis of Unidentified Etiology: Insights from a Mixed-Methods Study
Panciu, A.-M., Stoichitoiu, L. E., Moroti, R., & Hristea, A. (2025) · Microorganisms · doi:10.3390/microorganisms13081747 · Cited by 2 · see citing works
Jiang, H., Yu, X., Fan, J., Song, H., & Yang, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5518056/v1
MENINGOENCEFALITE VIRAL: O QUE O CLÍNICO PRECISA SABER?
Freitas, V. H. M., FREITAS, A. A. D., HERBESTE, E. A., Farias, J. P. B. D. A., CAVALCANTE, D. V., Nogueira, J. V. M., Cerqueira, G. S., PINHEIRO, M. D. A., & MOURA, A. E. F. (2023) · Editora Pasteur eBooks · doi:10.59290/978-65-6029-069-3.2
EFEITOS DA AURICULOTERAPIA NOS NÍVEIS DE ANSIEDADE EM PESSOAS OBESAS E PÓS-COVID-19
Nascimento, M. D. S. G., ́Ada, B. B. D., do Amaral, V., & Oliveira, R. G. (2023) · doi:10.22533/at.ed.25723310513
Pediatric acquired brain injury
Nelliot, A., Evankovich, K. D., Fisher, K. S., Davis, K. C., Gordon‐Lipkin, E. M., & Risen, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824060-1.00052-3
Meningite aguda: uma revisão da literatura
Almeida, C. D. A., Neto, E. D. S. R., Ferreira, F. R. S., Jucá, M. B., Duarte, M. D. C. M. B., & Torres, L. C. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n2-251
Девдариани, Х. Г., Kosherova, B., Mkhitaryan, X. E., Pozdnyakova, Y., Dyusembaeva, A., & Алшынбекова, Г. К. (2026) · Epidemiologia · doi:10.3390/epidemiologia7040115
Viral Meningitis in Children and Hearing Loss
Kara, B., Güngör, M., Arısoy, E. S., & Demmler‐Harrison, G. J. (2023) · Comprehensive ENT · doi:10.1007/978-3-031-38495-0_24
- Authors
- Kohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M.
- Affiliations
- Qatar University (QA)
- Corresponding author
- Yassine, Hadi M.
- Venue
- Archives of Virology
- Published
- 2021-01-03
- Volume
- 166
- Issue
- 2
- Pages
- 335-345
- ISSN
- 0003-9012 (ISSN-L)
- 0304-8608
- 1432-8798
- PMC
- PMC7779091
- OpenAlex
- W3118367501
- Cited by
- 164
- References
- 117
- Citations by year
- 2026: 29 · 2025: 35 · 2024: 40 · 2023: 34 · 2022: 20 · 2021: 5 · 2019: 1
- FWCI
- 4.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Archives of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Qatar University QSpace (Qatar University) (submittedVersion)
- Funders
- Qatar University (QUST-2-BRC-2018-1, QUHI-BRC-20/21-1)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- viral meningitis, meningeal inflammation, enterovirus, herpesvirus, influenza virus, etiological agents, clinical features, diagnosis, pathogenesis, early diagnosis
- MeSH terms
- Animals, Humans, Meningitis, Viral, Viruses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review